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Arboviruses are viruses transmitted by hematophagous arthropod vectors. Many of these viruses 
pose a threat to human health. While some infections may be asymptomatic, others may produce febrile 
illness, or manifest in life threatening conditions. Symptomatic diagnosis of patients with generalized 
febrile illness can be confounded due to the various diseases that present clinically in the same manner, 
and a lack of available diagnostic tests. Surveillance efforts can be used to create awareness 
about the prevalence of neglected tropical arthropod-borne pathogens, such as Oropouche virus 
(OROV), and inform preparedness measures for disease outbreaks (SURVEILLANCE 
SENTENCE). OROV is an arbovirus and the etiologic agent of human and animal disease. The primary 
vector of OROV is thought to be the biting midge, Culicoides paraenesis, though Culex 
quinquefasciatus, Cq. venezuelensis, and Aedes serratus mosquitoes are considered secondary 
vectors. There are no vaccines, diagnostics, or robust surveillance systems in place for OROV 
despite OROV being found in human patients in numerous countries that share border with Colombia: 
Ecuador, Peru, Brazil. In this study, synthesis of known data through review of published literature 
regarding OROV and vectors was done to determine if ecological variables could be associated with 
OROV prevalence and thus inform targeted surveillance efforts in resource strapped environments. 
Some common features were observed more frequently than others, though no one characteristic 
was statistically significantly associated with the presence of OROV using logistic classification 
models. Although there have not been any documented cases of OROV in Colombia, the presence of C. 
paraensis, the primary vector of OROV has been documented. However, when nearly 700 febrile patients 
were screened for OROV, none were positive by RT-qPCR. This indicates that while Colombia is 
presumably ecologically suitable for OROV circulation (given the presence of the vector), OROV has not 
emerged in that region. Altogether, this research has identified a significant gap in our understanding of 
OROV circulation, the eco-environmental drivers of transmission, and its emergence potential and 
vii 
indicates that more research is needed to identify those variables that may serve as ecological markers for 
transmission and emergence. 
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1.1. Introduction to Arbovirus Transmission  
The term arbovirus (arthropod-born virus) refers to any virus that is transmitted by an 
arthropod vector 1, 2. A vector is an arthropod that is capable of acquiring and transmitting 
disease causing agents 1. These vectors are most often hematophagous (blood feeding) 
arthropods and include numerous species of mosquitos, biting midges, and ticks 1, 2.  
Vector competence is the ability of a vector to transmit a virus 3. For a vector to be 
considered competent for a particular virus, a series of events must take place within the vector 
itself. Generally, hematophagous arthropod vectors first must ingest a bloodmeal from a viremic 
host. The virus must then get past several barriers in the process of infecting and replicating in 
the arthropod vector. The route of the virus begins with acquisition from a bloodmeal, then 
infecting midgut cells, disseminating into secondary tissues, infecting salivary glands, and lastly 
being expectorated with vector saliva into a susceptible host during a subsequent biting event 4, 5. 
Arthropod vectors generally have four tissue barriers that a pathogen must surpass for 
transmission to occur. These barriers include the midgut infection barrier, midgut escape barrier, 
salivary gland infection barrier, and salivary gland escape barrier 6-8.  
Arboviruses are generally maintained in two different types of transmission cycles: the 
sylvatic cycle and the enzootic cycle. The sylvatic cycle is when the virus is maintained or 
amplified in a transmission cycle consisting of wild animals and associated vector species. An 
example of this is the cycle of Zika virus (ZIKV) transmission between sylvatic mosquitoes and 
non-human primates. In 1947 ZIKV was found isolated from a rhesus macaque in Uganda 9, 10. 
Within a year of this discovery, ZIKV was also isolated from the known yellow fever virus 
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(YFV) sylvatic vector, Ae. Africanus 9, 10.  This data suggested that ZIKV was circulating in a 
sylvatic transmission cycle between mosquitoes and non-human primates in the Zika forest, 
during which the mosquito becomes infected after ingesting virus from a non-human primate and 
transmitting virus to another non-human primate. In an enzootic cycle, viruses are maintained 
between humans and the vectors that feed on them. For example, YFV outbreaks in human 
populations led to the discovery of viral circulation between humans and the known urban 
mosquito, Ae. aegypti 11. Viruses can spillover from a sylvatic cycle to an enzootic cycle when 
there is contact between an infected arthropod vector and a human4. This can happen either when 
an infected arthropod is introduced into urban areas or when humans venture into arthropod 
habitats such as forests and jungles 12, 13. Spillover events often involve a bridge vector, or 
arthropod capable of feeding on both reservoir hosts and humans, bridging sylvatic and enzootic 
transmission cycles 14, 15.  
A combination of many factors plays a role arbovirus transmission. The arthropod vector 
itself must be competent for the particular virus. Vector distribution is a key factor in arbovirus 
transmission as the vector serves as a main source of pathogen transmission and expansion. 
Ecological characteristics such as temperature, land use, and access to water sources are 
important to the survival and maintenance of a particular vector life cycle 16-18. Reservoir hosts 
that are essential to the long-term maintenance and propagation of viruses must interact with 
arthropod vectors for the vector to contract and transmit the virus. In addition, for pathogens 
often times spillover events are aided by a bridge vector that connect the sylvatic and enzootic 
transmission cycles. This suggests that vector-human and vector-reservoirs must be within a 
certain proximity for these events to take place. Humans, reservoir hosts, vectors, and viruses are 
all required for successful, ongoing transmission of arboviruses 19, 20. 
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1.2.Human Health Risk  
Numerous arboviruses are major public health concerns 21, 22. Arboviral outbreaks cause 
clusters of febrile illness, neurologic conditions, neonatal defects, and fatalities in human 
populations 21. Disease burden can be measured in disability-adjusted life years (DALYs). 
DALYs are calculated using the sum of years of life lost and years lived with disability for any 
given disease-causing agent 23. Chikungunya (CHIKV), dengue (DENV), and Zika (ZIKV) 
viruses are three examples of such arboviruses that have resulted in outbreaks affecting human 
populations. In combination, these three arboviruses resulted in the loss of nearly 500,000 
DALYs in the Colombian population alone between the years of 2013-2016 23. Within a period 
of three years, the combination of these three viruses resulted in over 9 million cases of infection 
23. Of the nearly 500,000 DALYs, 31,000 were years of life lost (nearly 1,400 deaths) and 
460,000 were years lived with disability 23. These disabilities included post-DENV chronic 
fatigue, CHIKV related chronic arthritis, and ZIKV associated microcephaly and GBS 23.  
CHIKV does not result in a high mortality rate, but it causes fever, myalgia, headache 
and arthralgia in symptomatic patients. The arthralgia associated with CHIKV can be mild or 
severe and last anywhere from days to years 24. CHIKV has been found in Asia, throughout 
central and parts of South Africa, Asia, and islands off the coast of Africa including La Reunion 
and Madagascar 24. CHIKV is transmitted primarily by Aedes spp. mosquitoes and can infect 
humans, non-human primates, rodents, and birds 24. There is no currently licensed vaccine for 
CHIKV, and treatment involves symptomatic treatment with non-steroidal anti-inflammatory 
(NSAID) medication and fluids 24.  
DENV is the most common cause of arbovirus-related disease around the world, 
infecting 390 million people per year 22, 25. There are 4 serotypes of DENV, all of which typically 
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result in fever, rash, myalgia, and headache. Many cases of DENV are self-limiting but severe 
instances may be fatal 26. In severe cases, DENV can result in Dengue Shock Syndrome or 
Dengue Hemorrhagic Fever. DENV can be found throughout the world with many epidemics 
taking place in tropical and subtropical regions 26. Similar to CHIKV, DENV is primarily 
transmitted via Aedes spp. mosquitoes 25. Currently there is one DENV vaccine that is licensed 
but this vaccine is only recommended to be administered to patients that have been previously 
infected with DENV. The DENV vaccine was shown to increase the risk of severe DENV 
disease upon exposure to wild DENV infections27. There is no medication to cure DENV but 
patients with infection are treated to ease symptoms.  
Clinical manifestations of ZIKV include fever, headache, myalgia, rash, and 
conjunctivitis 28. Often times, ZIKV is mild but one of the most concerning aspects of 
contracting ZIKV during pregnancy is Congenital Zika Syndrome. This syndrome results in 
microcephaly, decreased brain tissue, and brain damage in newborns. ZIKV has also been 
associated with Guillain-Barre syndrome, which is an autoimmune disease that can result in 
paralysis 29, 30 . ZIKV has been found in the Pacific islands, Africa, Latin America, Asia, and 
North America 31. This virus is primarily transmitted by Aedes spp. mosquitoes but is also 
capable of sexual, blood-transfusion, and maternal-to-fetus transmission 32. There is currently no 
vaccine available for the prevention of ZIKV and infected patients 33.  
OROV, an arborvirus that is beginning to gain more recognition in South America, can 
present with generalized febrile illness in the early stages of infection like many DENV, ZIKV, 
or CHIKV infections 34. This virus was initially identified in 1955 in Trinidad in a forest worker 
and has resulted in clusters of infection in Brazil, Peru, Panama, Suriname, and most recently 
French Guiana 35-37. The presumptive primary vector for OROV is C. paraensis, while a number 
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of mosquito species have been implicated in the enzootic cycle including Cx. quinquefasciatus, 
Co. venezuelensis, and Ae. serratus 34, 35. Avian species, non-human primates, and sloths have 
been found to carry OROV but none of these have been definitively identified as a primary 
reservoir host 34, 35. OROV has been seen to result in encephalitis in severe cases, though this 
manifestation appears to be a rare occurrence 34, 35, 38. Oropouche Fever, caused by OROV, has 
been recognized as a neglected tropical disease of veterinary and public importance 39, 40. 
Increasing screening and surveillance for this virus in human and animal populations will help to 
gain knowledge about virus and vector distribution, reservoir hosts, and characteristic symptoms 
of OROV 41, 42. 
The commonalities of arboviruses can be seen with the examples of CHIKV, DENV, 
ZIKA, and OROV. Clinical presentation during the early stages of infection is of mild 
generalized febrile illness43. These viruses are all zoonotic and initially emerged from wild 
animal populations resulting in spillover event aided by arthropod vectors 28, 44. Preventative 
vaccination is not an option (with the exception of DENV, where a licensed vaccine is available 
but is not generally recommended for naïve populations) and treatment options are limited to 
palliative care and address of symptoms 27, 28, 33.   
Knowledge of viral circulation and distribution is often only gained after the virus has 
been identified42. Emerging viruses can be identified through surveillance programs for public 
health42. In addition, continued surveillance of emerging diseases throughout disease progression 
can reveal symptoms that may be virus specific. For example, after the ZIKV outbreak in Brazil 
in 2015 there was a marked increase in the number of infants born with malformations such as 
microcephaly45 . After surveillance efforts revealed the coincidental findings, a retrospective 
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study was done in French Polynesia from the 2013 ZIKV outbreak, which supported the 
association between ZIKV and microcephaly 46  
Symptomatic diagnosis of patients with generalized febrile illness can be confounded due 
to the various diseases that present clinically in the same manner (Table 1.1.)47-51 . This can lead 
to misdiagnosis and undetected circulation of emerging viruses 52, 53. It has been speculated that 
the number of ZIKV cases during the 2013-2015 outbreak in the Americas was underestimated 
because of misdiagnosis as either DENV or CHIKV 54. Surveillance efforts during outbreaks of 
generalized febrile illness where a variety of viruses are screened for could reveal the circulation 
of an emerging virus42. This surveillance would also differentiate diagnoses in locations where 
arboviral co-circulations exist such as Brazil 54. Accurate diagnoses through surveillance efforts 
also informs disease epidemiology by providing spatial and temporal data55. 
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Table 1.1. Generalized and Characteristic Symptoms of Select Viruses Producing Febrile Illness 
Virus Generalized Symptoms Characteristic/severe Symptoms 
Zika virus (ZIKV) Fever, myalgia, arthralgia, retro-
orbital pain, rash 
Fetal malformations (microcephaly, Guillain-Barre 
Syndrome), encephalitis 
Chikungunya virus (CHIKV) Fever, myalgia, headache, arthralgia, 
retro-orbital pain, rash 
Severe arthralgia (can be recurrent) 
Dengue virus (DENV) Fever, myalgia, headache, rash  Dengue Hemorrhagic Fever, Dengue Shock Syndrome 
Influenza Fever, headache, myalgia, fatigue Sore throat, nasal congestion, pneumonia 
Oropouche virus (OROV) Fever, headache, myalgia, arthralgia Meningitis/encephalitis 
Yellow fever virus (YFV) Fever, headache, myalgia, fatigue Jaundice, nausea, vomiting 
Severe acute respiratory 
syndrome coronavirus 2 
(SARS-CoV-2) 






Infectious disease surveillance is broadly defined as monitoring the health of a population 
56. The primary goal of surveillance is to monitor disease burden with the hopes of being able to 
identify future outbreaks and newly emerging pathogens 56. Disease surveillance involves 
multiple aspects to gather comprehensive data to create awareness about disease prevalence and 
make informed decisions regarding preventative and preparedness measures for outbreaks 56. 
Identifying potential outbreak locations for can be examined for a particular disease by 
examining known disease epidemiology57, 58. This data can then be used to educate preventative 
and treatment measures for affected populations56. Continued disease surveillance can monitor 
the progress of disease control to make adjustments as needed to protect populations efficiently56 
. Ultimately, by continued disease surveillance, being able to identify and readily respond to 
outbreaks would prevent an outbreak from overwhelming entire communities and spreading to 
others56, 59.  
 There are numerous methods of surveillance used around the world depending on the 
goals of the surveillance program 56. There are targeted methods of surveillance that seek 
specimens that meet a particular criteria for a specific disease or group of diseases in a given 
location56. In these cases, laboratory confirmation is typically required, and sample data is 
collected on an individual basis56. For example, OROV was found to be the etiologic agent of 
febrile illness in 2 patients in Brazil. These patients provided individual accounts of medical 
records, location, time off illness onset, and symptoms experienced60. On the other hand, some 
surveillance methods may be more generalized, by which specimens are collected on a routine 
basis and used to screen for various pathogens 56. An example of this is the surveillance system 
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for West Nile virus in the state of Louisiana, whereby mosquitoes are screened for the presence 
of virus in an effort to inform vector control efforts61. Regardless of the type of surveillance 
used, these tools are critical for being able to identify new and existing pathogens, inform 
preventative measures, and ultimately strive for increasing public health and awareness.  
 Environmental factors including temperature and precipitation are known to be related to 
arbovirus transmission 62, 63. Monitoring environmental trends and fluctuations such as 
temperature, precipitation, and humidity changes through environmental surveillance can be a 
useful tool to predict future arbovirus outbreaks 58, 64, 65 . Statistical and mathematical models 
built from ecological input data have frequently been performed to make predictions about future 
outbreak risks58, 64, 66. Prediction models are a useful tool to assess outbreak potential and 
mitigation measures, but those models still rely on input data that is provided to train an 
algorithm58, 64, 66. This input data is often generated from surveillance effort stemming from 
previous outbreaks, revealing the importance of efforts to generate and collect surveillance 
data58, 64, 66 .   
1.4. The Cost of Delayed Surveillance  
The most recent SARS-COV-2 pandemic illustrates the importance of continued 
surveillance for new and emerging diseases. The outbreak that began in Wuhan, China expanded 
worldwide resulting in more than 150 million confirmed cases and over 3 million deaths67 . This 
pandemic has also resulted in devastating economic losses, with an estimated 16.2 trillion-dollar 
economic loss in the United States alone68. A primary goal of disease surveillance is to be able to 
identify and respond to disease outbreaks, which may prevent such overwhelming outcomes. The 
use of predictive models have been for drive public health emergency responses. These models 
are able to estimate the size and timing of outbreaks, which help to prioritize treatment resources 
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and surveillance efforts during disease outbreaks69. During the COVID-19 pandemic, models 
were used to inform policies regarding physical distancing, testing, and dispersal of public health 
resources70.  
DENV circulates in over 100 countries worldwide, affecting nearly 400 million people 
annually71. A cost analysis reviewing the economic impact of DENV in Puerto Rico between 
2002 and 2010 revealed the economic cost of $46.4 million dollars 72. This estimate includes 
DENV illness, surveillance, and vector control methods, where the cost of illness made up $38.7 
million dollars (83%) of that cost 72. Of the $7.7 million dollars spent on vector control and 
surveillance, only $730,000 went to surveillance 72.  
After the ZIKV outbreak in the Americas in 2015, models were made to predict the 
number of new cases to be expected in addition to economic impacts associated with continued 
disease spread 73. It was predicted that roughly 12 million cases of ZIKV could occur annually in 
Latin America if ZIKV became endemic 73. It was also estimated that the economic cost of 
neurological disease caused by ZIKV would be about $2.3 billion dollars annually73 . While 
these are projected estimates, this data has the potential to be used for outbreak prevention and 
preparedness 58, 73.  
Emerging and re-emerging arboviruses and neglected tropical diseases should not be 
disregarded. The numerous outbreaks, mortality, morbidity, and economic losses produced by 
arboviruses such as ZIKV and DENV illustrate the importance of prioritizing neglected tropical 
diseases. In addition, emerging diseases that were previously unknown, such as COVID-19, have 
resulted in costly and deadly outbreaks, therefore emerging diseases should not be completely 
excluded as a possible diagnosis68.  
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1.5. Hypothesis and Rationale  
 Many arboviruses have proven to be pathogens of public health importance, including 
OROV. The dynamic nature of transmission involves the arthropod vector, reservoir hosts, and 
human hosts, but the identity and role of these pieces of the transmission system for OROV are 
relatively uncharacterized. Surveillance for pathogens like OROV is critical to gaining 
knowledge regarding these transmission dynamics and implementing mitigation efforts. My 
hypothesis is that ecological and environmental characteristics currently available from 
published literature can guide surveillance for OROV. My thesis will investigate 1) the known 
ecological features associated with OROV detection and 2) the presence of OROV as an 
alternative etiology of febrile illness in a Colombian clinical cohort. The goal is to ultimately 
























CHAPTER 2. CHARACTERIZATION OF THE ECOLOGICAL AND 
ENVIRONMENTAL FACTORS ASSOCIATED WITH THE PRESENCE 




The Peribunyaviridae family is a diverse group of viruses that encompasses 4 genera: 
Orthobunyavirus, Herbevirus, Pacuvirus, and Shangavirus. This revised classification system 
was recently put forth by the International Committee of Viral Taxonomy (ICTV), whereby the 
Bunyaviridae family was elevated to an order, Bunyaviridales 75. Accordingly, members of the 
Orthobunyavirus genus, which consists of 18 serogroups, have been isolated from numerous 
countries in South America, most often Brazil 38, 76-82. The largest serogroup in the 
Orthobunyavirus genus, the Simbu sergroup, contain viruses associated with both human and 
animal diseases and is comprised of 25 viruses, including Oropouche virus (OROV) 83, 84. 
 OROV, like all bunyaviruses, is an enveloped, negative-sense, single-stranded RNA 
virus, the genome of which consists of three separate segments: small (S), medium (M), and 
large (L). These S, M, and L segments encode for the nucleocapsid protein, surface glycoproteins 
(Gn and Gc), and the RNA-dependent RNA polymerase, respectively 74. Additionally, the 
OROV N gene encodes for non-structural proteins NSs and NSm 85, 86. Not only is the 
nucleocapsid protein the most abundant protein produced in infected host cells but it is also the 
most immunogenic and is the primary antigen to which host antibodies are made 74, 85.  
OROV is maintained in two cycles: the zoonotic cycle (also called the sylvatic cycle), 
and the enzootic cycle. In the zoonotic cycle, virus is maintained between vectors and wild 
animals, while in the enzootic cycle, the virus cycles between man-biting vectors and humans 35, 
39, 87  These two cycles sometimes overlap in the case of a spillover event, which can occur either 
when a human becomes inserted in the zoonotic cycle or when a vector is introduced into an 
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enzootic settings, sometimes through a bridge vector 88. OROV mosquito vectors, specifically 
Cq. venezuelensis, have been implicated in maintaining the sylvatic cycle of OROV in non-
human mammalian hosts such as non-human primates, sloths, and some avian species 35, 89 
(Figure 2.1.). The primary enzootic vector for OROV has been identified as the biting midge, 
Culicoides paraenesis 35, 90-92.  In addition to the primary vector, Culex quinquefasciatus, 
Coquillettidia venezuelensis, and Aedes serratus are mosquitoes that have been found to transmit 
OROV but are considered secondary vectors 35, 89, 93, 94. Each of these mosquito species has been 
implicated in maintaining the enzootic cycle for OROV, with Cx. quinquefasciatus also 
implicated in the zoonotic transmission cycle 35.  
 
 
Figure 2.1. Virus transmission. In the sylvatic cycle, the arthropod vector (black), feeds on an infected reservoir host 
(red), survives EIP and is able to transmit virus (orange) to a susceptible host (brown). During a spillover event, the 
arthropod vector (midge) contracts the virus, survives the EIP and transmits the virus to a human host.  
 
In order to transmit OROV, the midge must first take a bloodmeal from a viremic host, survive 
the extrinsic incubation period (EIP) – or time it takes for the virus to replicate and disseminate 
through the vector – and finally bite a susceptible vertebrate host, transmitting the virus (Figure 




Figure 2.2. Extrinsic incubation period. For successful transmission, the biting midge must survive the EIP, during 
which the following take place: 1. Biting midge takes a bloodmeal from a viremic host, 2. Bloodmeal enters hind 
part of the mid-gut in the abdomen, 3. Virus attaches and invades gut cells and replicate, 4. Progeny virus escape 
into hemocoel and secondary tissues (including salivary glands, 5. Virus replication takes place in salivary gland 
cells, after which viral progeny are released into salivary ducts, 6. Viral particles are released from salivary ducts 
upon its next bloodmeal.  
 
OROV has been associated with a human febrile illness with generalized symptoms such 
as fever, headache, and myalgia 80, 95-97. The first known case of Oropouche fever was described 
in Trinidad in 1955. The patient was a young male, whose occupation was to burn coal in the 
Melajo Forest, where he often slept 77. Neutralizing antibodies were detected in blood specimens 
from forest workers in various forested sites in Trinidad. Neutralizing antibodies were also found 
in serum samples of 7/52 monkeys throughout the area 77. Since then, there have been outbreaks 
of Oropouche Fever in Brazil, Ecuador, and Peru 81, 97, 98. In the past 2 decades, there has been 
progress in developing diagnostic tools for OROV and understanding the pathogenesis of this 
virus 99-102.   
Before the emergence of Zika and chikungunya in the western hemisphere, OROV was 
recognized as being the second most common arboviral cause of human febrile illness in Brazil, 
second to dengue virus 103. Though this virus is recognized as the etiologic agent of human 
disease and is known to infect animals, there is a scarcity in screening and detection outside of 
known areas associated with detected outbreaks 34, 104, 105. Nevertheless, there is increased call for 
expanded screening of OROV across South America due to the significant number of cases and 
symptom similarity to other arboviruses in order to accurately attribute disease with specific 
pathogens 34, 95. The objective of this systematic review (SR) is to characterize the locations 
EIP = 4-8 days
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where OROV surveillance efforts have either confirmed OROV presence or not, as well as those 
locations where surveillance studies have detected the OROV vector independent of virus 
detection.  
2.2. Material and Methods 
2.2.1. Search strategy 
To assemble the published literature regarding OROV, an online search in PubMed 
database was performed using the term “Oropouche”. We attempted more specific search terms 
using “Oropouche virus” AND “South America” but these compound search term drastically 
reduced the number of articles returned (77 compared to 143 with only “Oropouche”). In 
addition, an additional search was performed using Google Scholar using the terms “Oropouche 
Virus” AND “South America”.  
To characterize the ecological sites where the primary vector has been studied in South 
America, a second literature search was performed using Google Scholar with the search terms: 
“Culicoides paraensis” AND “South America”.  
2.2.2. Study selection 
2.2.2.1. OROV 
Inclusion criteria for the OROV studies was defined as the following: molecular and/or 
serologic detection, and epidemiological data. Exclusion criteria was defined as following: 
reviews, studies without primary data (modeling, assay design, phylogenetics, immunology, 
physiology, insecticide investigations), duplicate study populations, Oropouche location (not 
virus), thesis/dissertation, book/book chapter, inaccessible/untranslatable, vector competence 
studies.  The number of records were recorded and were included or excluded based on the 
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satisfaction of the defined criteria. Titles were first examined, followed by record abstracts, and 
whole paper analysis.  
2.2.2.2. Arthropod vector 
 Inclusion criteria for the arthropod vector of OROV were defined as the following: 
epidemiological studies and entomological studies including vector competence and surveillance, 
field observations, and abundance. Exclusion criteria was defined as the following: reviews, 
studies without primary data, duplicate study populations, thesis/dissertation, book/book chapter, 
and inaccessible or untranslatable articles. The total number of articles were recorded and either 
included or excluded based on the satisfaction of the defined criteria. Titles were first examined, 
followed by abstracts, and whole paper analysis.  
2.2.3. Data extraction 
2.2.3.1 OROV 
The records that satisfied all inclusion criteria with respect to OROV surveillance were 
examined for data extraction. Documented study features included: study date and location, 
detection of nucleic acid and/or antibodies, laboratory assay performed or vector competence 
studies, hosts tested and confirmed positive, and ecological settings.  
2.2.3.2. Arthropod vector 
Records that satisfied all inclusion criteria for the OROV arthropod vector were 
examined for data extraction. The data extracted from C. paraensis literature included: 
surveillance date and location, vector species collected, number of vectors collected, collection 
methods, ecological settings. Articles that were returned from the Google Scholar database with 
the search terms “Culicoides paraensis” and “South America” that concentrated on any 
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secondary vectors (Ae. serratus, Cq. venezuelensis, Cx. quinquefasciatus) for OROV were also 
included. 
2.2.4. Statistics 
To determine whether any of the eco-environmental variables affected the odds of an 
acute (PCR) or past (antibody) OROV case detection, we built a suite of logistic classification 
models, employing variable selection methods. All variables were run as independent variables. 
A data reduction method whereby the several variables were combined as below and run as a 
uni-, bi-, and tri-variate models for acute and past infections: 
a. “livestock,” “military,” “crops,” and “mining” were combined into a single 
“anthropological” variable. 
b. “river,” “dam,” and “pantanal” were combined into a single “water” variable 
c. “primary” or “secondary” forests were combined into a single “forest” variable 
A data reduction method whereby the several variables were combined as below and run as a 
uni-, bi-, and tri-variate models for the presence of the vector: 
d. “livestock,” “military,” and “crops,” were combined into a single 
“anthropological” variable. 
e. “river,” “dam,” “pantanal,” “swamp,” “streams,” “springs,” and “lakes” were 
combined into a single “water” variable 
f. “primary,” “secondary,” “mangrove,” and “restiga” forests were combined into a 
single “forest” variable 
The logistf function was used (package logistf) to fit the models using R Studio (version 
1.3.1093) and R version 3.6.3. Significance was assessed at the the !=0.05 level. 
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2.3. Results 
2.3.1. Study selection 
A literature search in PubMed with the term “Oropouche” returned 140 records. A 
separate literature search in Google Scholar with the terms “Oropouche virus” AND “South 
America” returned 598 records. An additional search in Google Scholar regarding the primary 
arthropod vector for OROV was done using the terms “Culicoides paraensis” AND “South 
America” returned 173 records. Duplicate records across databases (“Oropouche” in pubmed and 
“Oropouche virus” in google scholar) and any article that did not satisfy the parameters of our 
inclusion criteria were excluded. A total of 94 articles, which is only 10.3% of all returned 
records, satisfied all inclusion criteria. Of the 94 articles included, 63.8% involved the 
investigation of OROV while 36.2% of the studies were focused on entomological surveillance 
(Figure 2.3.). All articles that met inclusion criteria for literature search of OROV and C. 





Figure 2.3. Systematic review article inclusion and exclusion for OROV and C.paraensis. 
 
2.3.2. Locations from included studies 
2.3.2.1. OROV surveillance 
Across all 56 articles included for OROV surveillance, there were 8 separate countries 
where these investigations took place. There were 37 studies performed in Brazil (63%) 39, 76, 78, 
80, 94, 96, 97, 106-135, followed by 11 studies in Peru (18.6%) 43, 79, 98, 104, 136-142, with the remaining 
(18.6%) taking place in Ecuador 38, 43, 81, 95, 143, Paraguay 43, 144, Suriname 145, Trinidad 77, Bolivia 
43, and Costa Rica 146 (Figure 2.4.) 
Articles returned from search 
terms = 911 
Records after full text 
analysis = 94 Records removed = 24 
Records of OROV 
investigation = 56
Records removed = 175Records after abstract reviewed = 114 
Records removed = 622Records after title examination = 289




Figure 2.4. Locations identified by the SR of OROV where the virus has been detected 
 
2.3.2.2. Arthropod vector surveillance 
 There were 34 articles that met all inclusion criteria for our C. paraensis search. There 
were a total of 7 separate countries in which these surveillance efforts took place. There were 21 
(60%) articles that were based in Brazil 147-167, 6 (17.1%) studies in Peru 168-173, 4 (11.4%) in 
Argentina 174-177, and the remaining (11.4%) taking place in Colombia 92, Paraguay 176, Mexico 
178, and Suriname 179 (Figure 2.5.) 
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Figure 2.5. Locations where OROV vectors are distributed throughout S. America according to the SR for C. 
paraensis. 
 
2.3.3. OROV detection 
OROV detection studies involved both serological and molecular assays across a range of 
host species. OROV screening was performed on samples from humans, non-human primates, 
arthropods, mammals, avian species, and reptiles. Of the 56 articles that were focused on the 
detection of OROV, there were 46 serologic studies 38, 43, 76, 78-81, 94, 96-98, 104, 106-111, 113, 114, 116-118, 
120, 121, 124-128, 130-142, 144-146, 7 disease etiology investigations where OROV was confirmed 39, 77, 95, 
112, 115, 119, 143, and 3 diagnostic development studies 122, 123, 129.  
Several methods were used for the detection of both nucleic acid and antibodies: 
complement fixation (CF), hemagglutinatin inhibition (HI), neutralization tests, enzyme-linked 
immunosorbent assay (ELISA), plaque reduction neutralization test (PRNT), Indirect 
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immunofluorescence assay (IFA), virus isolation assays, real-time reverse transcription 
polymerase chain reaction (RT-PCR) and quantitative real-time RT-PCR (qRT-PCR), and 
Illumina based sequencing. Of these methods, the most commonly used for antibodies detection 
was ELISA, whereas the most commonly used method for the presence of OROV nucleic acid 
was RT-PCR.  
From the 56 articles included in OROV investigations, 9 (16%) of the total 56 studies 
found no presence of OROV 111, 116, 127, 130, 133, 135, 142, 144, 146, whereas 47 (84%) of the studies that 
screened for OROV found either antibodies to OROV (18 studies) 76, 78, 98, 106-109, 113, 114, 118, 120, 126, 
131, 132, 136-138, 145, OROV nucleic acid (16 studies) 38, 79, 81, 95, 104, 115, 117, 121-123, 128, 129, 134, 139, 140, 143, 
or both (13 studies) 39, 43, 77, 80, 94, 96, 97, 110, 112, 119, 124, 125, 133. Humans were tested for OROV 
antibodies (11 studies) 78, 98, 106-108, 126, 131, 132, 136, 137, 145, OROV nucleic acid (19 of studies) 38, 79, 
81, 104, 111, 115-117, 121-123, 127, 129, 130, 134, 139, 140, 143, 144, or both (17 studies) 39, 43, 77, 80, 94-97, 109, 110, 112, 119, 
120, 124, 125, 138, 141.  
Non-human mammals that were tested for OROV include: non-human primates, sloths, 
avian species, rodents, sheep, reptiles, and horses. There were 7 studies that tested non-human 
primates, 5 studies tested for antibodies 113, 114, 118, 133, 142, 1 for OROV nucleic acid 128, and 1 for 
both 135. There were 3 studies that tested samples obtained from sloths where 2 of these studies 
tested for antibodies 133, 146 and 1 study tested for OROV nucleic acid 94. Three studies tested 
avian samples for antibodies 96, 97, 126, 2 studies tested rodents for antibodies 97, 126, and 1 study 
that tested sheep, caiman, and equine samples for antibodies 76. 
 
2.3.4. Ecological Factors associated with OROV presence 
2.3.4.1. Vector presence  
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Of these 56 studies returned from the OROV search, 9 studies did not detect the 
circulation of OROV. In 8/56 of the OROV search studies, surveillance for known OROV 
vectors was conducted and presence confirmed of at least one competent species 77, 94, 96, 97, 113, 117, 
124, 125. Four of these 8 studies (3 in Para, Brazil 97, 117, 125 and 1 in Maranhão, Brazil 124) where 
OROV was found documented the presence of C. paraensis.  There were 7/56 studies that found 
mosquito vectors: Ae. serratus in 4 studies located in Trinidad 77 and Brazil (2 in Para State 94, 96 
and 1 in Mato Grosso do Sul State 113), and Cx. quinquefasciatus in 3 studies in Brazil (Para 
State 97, 125 and Mato Grosso State 117). In 2/8 studies, C. paraensis and Cx. quinquefasciatus 
were both found in Para, Brazil 97, 125, while in another separate study in Para, Brazil, C. 
paraensis and Ae. serratus were both found96.  
2.3.4.2. Vector Diversity  
Of the studies that satisfied the vector criteria, 20 of these articles focused on surveillance 
of the OROV primary vector, C. paraensis 92, 147, 148, 157, 158, 160-165, 167, 170-172, 175-179. Even though 
the search criteria specified the terms “Culicoides paraensis” and “South America”, there were 
14 articles that focused on one or more of the secondary mosquito vectors: Ae. serratus, Cq. 
venezuelensis, Cx. quinquefasciatus 149-156, 159, 166, 168, 169, 173, 174. Of the 34 articles, C. paraensis 
was found in 18 studies 92, 147, 148, 157, 158, 160-165, 170, 171, 175-179, and each of the 3 mosquito vectors 
was present in 7 studies, some of which overlapped 149-156, 160, 168, 169, 174 (Figure 2.6.).  
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Figure 2.6. There were 29/34 entomologically focused studies where OROV vectors were collected. There was 
overlap in mosquito populations in 7 studies. In 1 study, both the biting midge and a mosquito vector (C. paraensis 
and Cx. quinquefasciatus) were found.   
 
  
2.3.4.3. Anthropogenic Land use 
For the OROV search, 15/54 (27.8%) articles provided information regarding 
anthropogenic land use. The uses of land in these locations were crop cultivation, livestock 
rearing, military outposts, and mining at a frequency of 11 77, 80, 96, 97, 124, 125, 131, 133, 136, 137, 146, 6 76, 
80, 97, 124, 131, 146, 3 81, 98, 142, and 1 125, respectively (Figure 2.7.). The 2 most common land uses, 
crop cultivation and livestock rearing, were both present in 5 of studies 80, 97, 124, 131, 146.  
 There were 13/34 studies from the C. paraensis search that described land use (Figure 6). 
The most common use of land was crop cultivation (9 studies) 92, 147, 152, 155, 156, 171, 175, 177, 179, 
followed by livestock (7 studies) 147, 158, 164, 166, 169, 171, 175. In studies, crop cultivation and 

























Figure 2.7. (Blue) There were 18/56 studies that including information about anthropogenic land use. The two most 
common themes were agriculture and livestock, which overlapped in some locations. (Red) There were 13/34 
studies with information about study site land use. There were 3 studies where livestock and cultivation overlapped. 
 
2.3.4.4. Water source 
In 19 of the 56 articles focusing on OROV surveillance, a nearby water source was noted 
(Figure 7). In 14 locations there was at least one river present 36, 97, 98, 106, 113, 124, 126, 127, 131, 135-138, 
146. Other sources of water were noted but to a much lesser extent with 3 locations in the 
Pantanal (the largest tropical wetland in the world) 76, 114, 117, 2 locations in a coastal area 119, 123, 
and 2 location near a dam 36, 132.  
 We found that water sources were mentioned in 21 of the 34 articles regarding C. 
paraenesis surveillance (Figure 2.8.). The presence of at least 1 river was described in 11/21 
articles 147-149, 152, 160, 161, 169, 173, 176, 177, 179. Streams were the second most frequently mentioned in 
5 articles92, 156, 157, 175, 177. There were 4 studies that noted marshes/swamps 156, 166, 174, 179, whereas 
























sources mentioned twice each. There was 1 location where surveillance took place at the site of a 
dam 149 and 1 study that took place in the Pantanal 150.  
 
  
Figure 2.8. (Blue) 19/56 studies including information regarding water sources in their study areas. Overlap in water 
sources in 1 location. (Red) There were 21/34 studies with information about water sources. There were overlap in 
marshland, lakes, and springs. 
 
2.3.4.5. Land Cover  
There were 21 (38.9%) articles that made observations regarding land cover from the 56 
studies that focused on OROV surveillance (Figure 2.9.). Locations that have primary or 
undisturbed forest were most common, mentioned in 16 studies 39, 43, 77, 79, 81, 95-98, 127, 133-136, 139, 
142. Secondary forests, or forest locations that had been previously used for anthropogenic 
purposes were found in 2 studies77, 137. A cerrado land cover, which consists of bushy, small bent 
and twisted trunk trees, was described in 4 locations 113, 114, 117, 134, while 2 locations described 
mountainous terrain 79, 125.  
 Of the 34 studies from the C. paraensis search, 26 (76.5%) that made note of the land 




































































165, 166, 169, 171, 174-177, 179 and 11 studies 147, 149, 151, 153, 155, 159, 166, 168, 169, 171, 173, respectively. There 
were 3 surveillance studies that took place in locations described as cerrado 150, 151, 179, while both 
mangrove 158, 179 and restinga land cover 165, 167 types were mentioned. Restinga refers to coastal 
forests with the soil mostly consisting of sand and salt. There were several studies that had 
overlapping types of land cover which included cerrado, primary forest, and secondary forest 
locations 150, 151, 165, 166, 169, 171, 179.   
 
Figure 2.9.  (Blue) There were 21 studies that included information about the land cover of the study area. There 
were overlap of land cover types in 3 locations. (Red) There were 26/34 studies with information about the land 
cover types associated with the study sites. There were overlaps in primary and secondary forest, primary forest and 
cerrado, cerrado and secondary forest, primary forest and restinga, and one study included mangrove, cerrado and 
primary forest sites. 
 
2.3.5. Statistical analysis 
2.3.5.1. Odds of Detecting Acute and Past Infections 
The full model run with all 12 variables did not converge for either the dataset built on 
pcr prevalence (acute infections) or antibody prevalence (past infections). The use of high 
computing power may allow for convergence in future but was not available at the time of 





























reduction method and ran the model with uni-, bi-, and tri-variate combinations of the 
variables related to anthropological land-use, the presence of water, and/or forests. In none of 
the models were any variables significant for either the acute or past infections. 
2.3.5.2. Odds of Vector Presence 
Similarly, the full model of 17 eco-environmental variables for determining differences in 
odds of detection of the vector species did not converge. None of the uni-, bi-, or tri-variate 
models run using the data reduction methods returned significant results. This suggests that, 
in South America, there is still not enough data available to determine whether the detection 
of Culicoides pariensis is likely to be associated with specific eco-environmental variables.  
 
2.4. Discussion 
Our primary objective was to assemble the existing data regarding the environmental and 
ecological factors associated with known detection of OROV in South America, and to likewise 
identify factors associated with the presence of the primary enzootic vector. Our review of the 
published data demonstrates that there are similarities among the factors observed in OROV and 
vector detection. First, the most prominent anthropogenic land use observed was crop cultivation 
and livestock for both OROV and vector presence. Secondly, rivers were the most common 
source of water in locations where OROV and arthropod vectors were documented. Lastly, both 
OROV and vectors were more frequently found in primary forest locations.  
Because OROV is an arbovirus, the presence of a vector is paramount to the likelihood of 
virus detection 90, 91. Arbovirus transmission potential is measured largely by the vectorial 
compacity equation, which investigates key variables including such factors as vector density 
relative to humans, and extrinsic and intrinsic factors that govern the virus-vector dynamics 180. 
Often, the processes of transmission within the vector - vector competence and the EIP – are 
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affected by environmental factors, most notably temperature, which can vary in response to 
anthropogenic land use, land cover, and proximity to water 18, 20, 181, 182. Therefore, these 
environmental and ecological characteristics are crucial factors that should be considered in 
OROV transmission and when planning efforts aimed at detecting this potentially emergent 
arbovirus.  
  For example, because a good portion of the C. paraenesis lifecycle includes semi-aquatic 
stages, these arthropods are often found in moist, decaying vegetation such as that from recently 
harvested farms 182. C. paraensis often lay eggs in moist areas, where developmental stages 
progress through the lifecycle by feeding on decomposing organic matter, algae, and small 
vertebrate prey 182. The necessity of water to the lifecycle of C. paraensis (as well as the 
secondary mosquito vectors) increases the likelihood of finding these arthropods in close 
proximity to water sources 182. In addition, water is an attractant to susceptible vertebrate hosts in 
both uninhabited and inhabited locations, which leads to host-vector interactions necessary for 
arboviral transmission in the context of potential reservoir hosts, such as avians, non-human 
primates, and rodents 18. While C. paraensis is known to feed on humans, their opportunistic 
feeding patterns lead them to feed on other vertebrate hosts in lieu of human presence 182. In 
addition, forested environments suitable for reservoir hosts enables arthropod vectors to both 
acquire and transmit OROV 18, 182.  
The increasing demand for agricultural and industrial products has resulted in worldwide 
globalization183. The proceeding economic expansion into S. America centers around crop 
production, especially soy, while some areas also take part in the livestock trade 183, 184. In 
addition, mining for bauxite, nickel, and gold have had a positive impact on economic 
development in this region 185. However, these economic gains have had unintended 
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consequences whereby previously uninhabited forest are now in closer proximity to human 
populations and/or human enterprises. This, in turn, increases the chances of zoonotic spillover 
events by increasing contact between vector and reservoir vertebrate host populations 88.  
There are numerous locations across regions of South America where investigations into 
the presence of OROV have successfully identified circulation of the virus; however, it is 
noteworthy that there are geographic gaps in OROV surveillance efforts. These data demonstrate 
that there was no evidence of surveillance for OROV is noted in Colombia, Venezuela, and 
Guyana, even though all three of these countries border Brazil. Colombia, particularly, borders 
three countries where OROV has been identified (Figure 3A). Further, of the included records 
the Google Scholar “Culicoides paraensis” and “South America” search, entomological 
surveillance efforts for the primary vector of OROV in South America are predominantly in 
Brazil, especially on the easternmost portion of the country (Figure 4). 
There are obvious gaps in the literature concerning OROV, a neglected tropical, zoonotic 
disease of emergent public health importance. The most surveillance has been conducted in 
Brazil (Figure 2). While one C. paraensis surveillance study in Colombia verified the presence 
of the vector, entomological surveillance specific to C. paraensis was also found to be primarily 
concentrated in Brazil, with sporadic surveillance locations in Peru and Argentina 157, 170, 177. 
Additionally, our review provided a preliminary characterization of ecological and 
environmental factors that may be associated with increased chances of OROV detection and 
perhaps circulation. However, continued research is needed to fully elucidate OROV 
transmission dynamics, arthropod vector competence, and OROV distribution in order to prepare 




There were notable common ecological aspects associated with both the locations 
involved in OROV detection and the presence of the vector in the 94 studies included in this 
systematic review. Ecological characteristics included in both OROV and arthropod vector 
surveillance studies had crop cultivation as the most common anthropogenic use of land, rivers 
as the most common water source, and primary forest as the most prominent type of land cover.  
The observations found within this systematic review illustrate the importance of including 
research into the ecological factors associated with the distribution of under-characterized 
arboviruses. This review reveals the need for continued surveillance for OROV and its arthropod 
vector, and the description of factors associated with detection may help to prioritize OROV 
























CHAPTER 3. OROV AS A POSSIBLE ETIOLOGY FOR FEVERS OF 




 Arboviruses are a cause of public health concern due to the variety of clinical symptoms 
ranging from mild febrile illness to death 21, 22. Zika virus (ZIKV), dengue virus (DENV), 
Chikungunya (CHIKV) virus, and yellow fever virus (YFV) are well-known arboviruses that can 
result in a number of human illnesses 21. These viruses can have similar symptomology 
spectrum, which includes a mild febrile illness 28, 43, 48, 71. A lack of resources available to 
diagnose and treat patients can also lead to misdiagnosis or an ultimate lack of definitive 
diagnosis. In these cases, patients are released with a non-descript diagnosis of fever of unknown 
origin. In fact, studies published from 1961 to 2007 show an increasing trend from 9.0% to 
51.0%, respectively, in a result of no specific diagnosis of febrile patients 186. 
With the emergence of new viruses, and/or increase in cases of existing viral febrile illness, 
there is a need to expand screening of febrile patients for viruses that may not be immediately 
considered in differential diagnosis. Determining the presence or absence of arbovirus circulation 
in human populations, especially in febrile populations, would lead to a more comprehensive 
view of disease burden resulting from a specific virus. Further, increasing the knowledge of viral 
presence and circulation can inform efforts of surveillance and prevention programs42 .  
OROV has been found in human patients in numerous countries that share border with 
Colombia: Ecuador, Peru, Brazil 34, 35. Although there have not been any documented cases of 
OROV in Colombia, the presence of C. paraensis, the primary vector of OROV has been 
documented in Colombia 92. We undertook to test a clinical cohort of febrile patients from 
Colombia to determine if the fevers were due to acute infection with OROV.  
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3.2. Materials and Methods 
3.2.1. Patient samples 
Serum samples were obtained between 2013 and 2015 from patients in Colombia at Ese Hospital 
Universitario Erasmo Meoz, Ese Hospital de Los Patios, Ese Hospital Emiro Quintero Cañizares, 
from the regions of Cucuta, Los Patios, and Ocaña, respectively (LSU IRB protocol #3415). 
Patients were classified as patients with suspected DENV, healthy controls, and non-DENV 
febrile control patients.  
3.2.2. Cell culture and virus growth 
OROV DEI 209 was isolated from human serum in a patient from Iquitos in 1995 and provided 
by the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA), Galveston, 
TX. The virus was received as lyophilized stock and reconstituted in 1 mL of BA-1 diluent (10% 
Medium 199 (10X), Earle’s Salts, 1% Pen/Strep/Fungizone, 10% Bovine Serum Albumin, 0.6% 
Tris-HCL, 0.47% Sodium Bicarbonate 7.5). Virus was then passaged once on Vero cells (ATCC 
CRL-2587). Vero cells were grown at 37°C and 5% CO2 in optimal medium (88% Medium 199, 
Earle’s Salts, 10% Fetal Bovine Serum, and 2% Antibiotic-Antimycotic). Confluent Vero cells in 
a T25 flask were inoculated with 50uL OROV and supernatant was collected at 2 dpi (days post 
inoculation). Frozen viral stocks of DENV serotype 2, strain 1232 that was passaged 10 times on 
Vero cells was used for all DENV experiments 3.  
3.2.3.  OROV characterization 
3.2.3.1.  Growth Curve 
To determine the in vitro growth kinetics of OROV, in our laboratory, aliquots of 200 uL was 
collected on days 1, 2, 3, 5, and 7 post-inoculation on to confluent Vero cells. RNA was 
extracted using the QIAmp Viral RNA Mini Kit per manufacturer’s instructions. 100 uL of 
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sample was added into 400 uL of AVL buffer and gently mixed followed by a 10-minute 
incubation for virus inactivation. 400 uL of ethanol was added to the mixture and briefly 
vortexed. Mixture was then added to the Qiagen Mini spin column and centrifuged. Filtrate was 
discarded and 500 uL of AW1 solution added to the Qiagen Mini spin column and centrifuged. 
Filtrate was discarded and 500 uL of AW2 solution was added to the Qiagen Mini spin column 
and centrifuged. Filtrate was discarded and 60 uL of Elution AVE was added to the Qiagen Mini 
spin column and was incubated then centrifuged. The resulting filtrate is extracted viral RNA 
from original sample. Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-
PCR) was performed on extracted viral RNA as described below. The growth curve for OROV 
revealed maximum growth on 3 dpi.  
3.2.3.2.  Plaque Assay and Viral Titer Determination 
Vero cells were grown as described above in T75 flasks until confluent. Growth media was 
removed, and cells were trypsinized then seeded in 6-well plates. Cells were monitored for 12-24 
hours until 100% confluent and adhered to well bottoms. A 10-fold virus dilution series was 
prepared from -1 to -7. Growth media was removed, and cells were inoculated with respective 
dilutions then plates were rocked for 30 minutes. 2 mLs of overlay mixture that consisted of a 
1:1 ratio of media (0.2% 10X Medium 199, Earle’s Salts, 0.032% Sodium Bicarbonate, 0.05% 
1M Hepes, 0.02% Pen/Strep/Fungizone, 0.2% Fetal Bovine Serum, 0.49% water) and agar (0.25 
g SeaPlaque agar power dissolved in 25 mLwater) was applied to cell layers. Plates were 
incubated at 37°C and 5% CO2 until plaque were noticed under microscopic examination. On 
day 4 post inoculation 3 mLs of 10% formaldehyde solution was applied to each well for 1 hour. 
Formaldehyde waste and overlay were moved and 1 mL of 0.35% crystal violet solution was 
applied to each well. Plates were incubated for 15 minutes, crystal violet was discarded, plates 
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were rinsed with water and allowed to dry overnight. Plaques were counted and the titer of 
OROV was calculated to be 8.73 x 107 PFU/mL. The titer of DENV serotype 2 strain 1232 was 
calculated to 4 x 107 PFU/mL.  
3.2.4. RNA Extraction and qRT-PCR assays 
RNA was extracted using the KingFisher (ThermoFisher) robot and the Ambion MagMag viral 
isolation kit (ThermoFisher), per manufacturer’s instructions. Extracted RNA samples were then 
tested for the presence of OROV RNA using the OROV S segment previously published 
101(Table 3.1.). In addition, samples were screened for the presence of DENV RNA using a pan-
DENV primer and probe set previously published187 . All primers and probes used are listed in 
Table 3.1. Prior to experiments, primer and probe pairs were tested on appropriate viral stocks 
for validation. OROV qRT-PCR screening was performed by preparing of mixture of 10µL 2X 
RT buffer, 1µL Forward primer (10 µM), 1µL Reverse primer (10 µM), 0.4 µL Probe (20 µM), 
0.4 µL SIII Taq, 1.4 µL ddH2O, 0.8 µL MgSO4 and 5µL sample RNA was used on 96-well PCR 
plates. After being loaded, plates were centrifuged for 2 mins at 2000 rpm prior to nucleic acid 
amplification on a Roche LightCycler 96. The OROV S segment screening involved the 
following thermocycling parameters: reverse transcription at 50°C for 300 seconds, then 95°C 
for 20 seconds, and 2-step amplification at 45 cycles of 95°C for 3 seconds and 60°C for 30 
seconds 101. DENV qRT-PCR was performed by preparing a mixture of 10µL 2X RT buffer, 1µL 
Forward primer (10 µM), 1µL Reverse primer A (10 µM), Reverse primer B (10 µM), 0.4 µL 
Probe (20 µM), 0.4 µL SIII Taq, 0.4 µL ddH2O, 0.8 µL MgSO4 and 5µL sample RNA was used 
on 96-well PCR plates. After being loaded, plates were centrifuged for 2 mins at 2000 rpm prior 
to nucleic acid amplification on a Roche LightCycler 96. To detect DENV the following 
thermocycling parameters were applied: reverse transcription at 45°C for 30 seconds, then 95°C 
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for 5 minutes, 2-step amplification at 45 cycles at 95°C for 45 seconds and 57°C for 35 seconds 
187. Each qRT-PCR run included a positive hand extracted RNA sample from the target virus and 
two negative controls (molecular grade water, PCR mixture without sample RNA). Samples with 
a Cq value of ≤ 35 were considered positive.  
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Table 3.1. Primers and Probes used for qRT-PCR 
 
Virus and target segment Primer and 
Probe 
Sequence Tm °C 
OROV Small segment  Forward primer 5’ TCCGGAGGCAGCATATGTG 3’ 57.3°C 
Reverse primer  5’ ACAACACCAGCATTGAGCACTT 3’ 57.6°C 
Probe 5’ (FAM) CATTTGAAGCTAGATACGG 3’ 47.8°C 
Pan-DENV 3’ noncoding 
region  
Forward primer  5’ GGATAGACCAGAGATCCTGCTGT 3’ 57.7°C 
Reverse primer 
A (1:1) 
5’ CATTCCATTTTCTGGCGTTC 3’ 52.3°C 
Reverse primer 
B (1:1) 
5’ CAATCCATCTTGCGGCGCTC 3’ 59.4°C 
Probe 5’ CAGCATCATTCCAGGCACAG 3’ 57.9·C 
 
*Reverse primer A and B were mixed at a 1:1 ratio
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3.3. Results 
Human serum samples available from Cucuta (n = 176), Los Patios (n = 262), and Ocaña 
(n=261) that were classified as “suspect DENV” patients or “febrile, not DENV suspect” patients 
(Table 3.2.). Each of these samples were screened for DENV and OROV. Of the 699 samples, 
608 (87%) of them were collected as “DENV suspect” patients, whereas only 91 (13%) were 
classified as “febrile, not DENV suspect” patients. Sample demographics are described in table 
3.2.
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Table 3.2. Human Serum Sample Demographics 
 
Location Cucuta DENV 
Suspect 
(n=176) 
Los Patios DENV 
Suspect (n=186) 
Los Patios Febrile, non-
DENV suspect (n=76) 




DENV suspect (n=15) 
Total (n=699) 
Male 89 102 41 107 11 350 
Female 87 84 34 139 4 348 
Age 0-15 153 99 39 105 8 404 
Age 16-30 16 45 13 78 4 156 
Age 31-45 2 9 12 34 1 58 
Age 46-60 4 17 2 21 2 46 
Age 61+ 1 16 10 8 0 35 
2014 
Collection 
0 129 11 111 0 251 
2015 
Collection 
176 57 65 135 15 448 
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 We found that only 19 out of the total 699 samples were DENV positive via qRT-PCR, 
while there were no positive samples for OROV. Of these positive DENV samples, 2 of them 
were categorized as “febrile, not DENV suspect” patients. In Cucuta, of the 176 samples 
screened for DENV, there was 1 positive sample (0.006%). This patient was classified as a 
“DENV suspect” patient. There was 262 samples tested from Los Patios and 12 of these were 
positive for DENV (0.046%). A total of 261 samples were tested for DENV from Ocaña, 
revealing 6 positive patients (0.02%).  Each of these 6 patients were classified as “DENV 
suspect” patients. Of the 12 positive samples from Los Patios, 10 of the samples were collected 
from “DENV suspect” patients, whereas 2 samples were in the collected from the group of 
“febrile, not DENV suspect” patients.  
All samples were negative for OROV S segment via RT-qPCR. The S segment was 
targeted to expand upon our surveillance efforts, encompassing OROV reassortants Iquitos virus 
(IQTV), Madre de Dios virus (MDDV), and Perdões virus (PERDV). Each of these OROV 
reassortants contain the same S segment 87. These results reveal that 680/699 (97%) of the 
patients experienced febrile illness from etiologic agents other than OROV and DENV. 
3.4. Discussion and Conclusions 
The clinical manifestation during the early stages of OROV infection mimic those of 
other arboviruses endemic in Latin America 43. This can lead to misdiagnosis and 
underreporting, therefore skewing any epidemiological data available 35. Because of the non-
specific generalized febrile illness associated with the majority of OROV infections, testing for 
OROV should not be completely ruled out.  
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Our results involved screening 699 human patient serum samples for the presence of 
OROV and molecular confirmation of acute DENV. This illustrates the importance of additional 
screening for various etiologic agents of febrile illness in Colombia, however we demonstrated 
that the inclusion of OROV did not reveal the etiology of these non-specific pathologies. Broader 
surveillance for OROV can be done by the addition of other detection methods, expanding 
geographical ranges, and OROV reservoir and vector surveillance.  
There are a variety of pathogens that cause febrile illness in the Colombian human 
population and may be undiagnosed etiologies in cohorts such as this. Viruses including YFV, 
ZIKV, DENV, CHIKV, Mayaro virus (MAYV), and Venezuelan equine encephalitis virus 
(VEEV) are all arboviruses transmitted by arthropod vectors and can result in febrile illness 28, 
188-190. In addition, parasites that cause malaria and chagas disease, which are transmitted 
mosquitoes and triatomine bugs, respectively, cause febrile illness and have been found to 
circulate in Colombia 191-193. Rickettsia, a tick-borne disease resulting in febrile illness during 
human infections has also been found in Colombian populations 194. Additionally, there is still 
the potential for febrile illness to stem from currently unknown or neglected emerging pathogens. 
 By increasing surveillance for arboviruses in human, vector, and animal populations, we 
can close some of the knowledge gaps regarding neglected tropical disease epidemiology 
including transmission, distribution, and characteristic disease symptoms. This could also inform 







 Arboviruses are a continuing threat to human and animal health as vectors, 
viruses, and hosts are increasingly interacting through expanding urbanization and 
globalization12. Urbanization as a result of population growth has increased the interface of 
vector and human interaction, especially with those vectors that are anthropophilic 12, 13. 
Arboviral vectors such as Aedes mosquito spp. have expanded their geographic range and are 
found worldwide 195. Expanding globalization and world travel aids in the disease spread 
potential by facilitating pathogen spread between countries 196. Surveillance efforts are needed to 
monitor emerging pathogens more than ever because of these factors contributing to the potential 
for disease spread worldwide 13, 196. The advances in research and medical fields only enhances 
the speed at which promising solutions can be reached for prevention and treatment upon a threat 
or outbreak of an emerging disease 197, 198.   
Arbovirus spread has been found to occur for decades or more as Eastern hemisphere 
viruses are introduced and expand into the Western hemisphere. Yellow fever virus, CHIKV, and 
ZIKV are examples of arboviruses that originated in the Eastern hemisphere and were introduced 
into the Western hemisphere, resulting in large outbreaks with high levels of morbidity and 
mortality in naïve populations 199. The occurrence of these outbreaks prompted increased 
research efforts to understand transmission, pathogenesis, treatment, and prevention to combat 
future outbreaks199. Increasing knowledge of a pathogen is valuable for the next steps to prevent 
further viral spread and economic damage56, 200, 201 . This supports the need for surveillance 
efforts to gain knowledge about potential disease-causing pathogens and could aid in prevention 
of large outbreaks before they occur or be able to initiate a response in a timely manner to an 
outbreak 42, 57, 202.  
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Ecological characteristics such as temperature and precipitation are known to have effects 
on arbovirus transmission 62, 63. These factors have been used to train data sets to make 
projections for future arbovirus outbreaks 58, 64. Knowledge regarding transmission dynamics of 
OROV is still being researched as more outbreaks are occurring, specifically in Latin America100, 
203. While OROV has been found in these areas, it has been included in diagnostic algorithms  
after more common arboviruses have been ruled out via diagnostic methods such as PCR39, 104 .  
The addition of OROV screening to passive surveillance systems could close some gaps 
in knowledge regarding the number of OROV cases and virus distribution 34, 37. In addition to 
patient sample screening, implementing arthropod surveillance for OROV could reveal the 
presence or absence of OROV in urban and sylvatic arthropod populations. Vector surveillance 
could also inform preventative measures for human exposure to potentially infectious arthropods.  
The objective of the systematic review in Chapter 2 was to use published literature to 
identify economical and environmental characteristics to aid in guiding surveillance efforts. We 
were hoping to use this data to inform locations that would have a higher likelihood of detecting 
the presence of OROV. Ultimately, this data did not reveal any significant differences among 
ecological and environmental characteristics between 3 Colombian locations: Cucuta, Los Patios, 
and Ocaña.  
In Chapter 3, the goal was to screen for the presence of OROV in a clinical cohort of 
febrile patients from Colombia. Without any clear location to prioritize, we tested all available 
human serum samples from each of the three locations to determine if differences existed in the 
detection of OROV. Each of the samples was from a patient presenting with febrile illness. Each 
of these samples was tested via RT-qPCR for OROV and DENV. DENV was tested due to its 
endemicity in Colombia and the antibody-based test for DENV suspicion in the clinic. We found 
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that none of the patients had an acute infection of OROV, while 19 out of 699 patients were 
positive for DENV, despite 608 samples being classified as DENV-suspect from the clinical 
data. This could be due to the nature of DENV diagnostics, which is antibody based (IgM and 
IgG) and which therefore detect convalescent infections. Regardless, this suggests that other 
etiologies are responsible for a majority of fevers of unknown origin, but that OROV is not likely 
to contribute to that burden of disease in Colombia.   
Gaining insight into pathogen transmission, distribution, and characteristic disease 
symptoms can aid in preventative measures, preparedness, and response (e.g., targeted vector 
control). Ultimately, augmented surveillance data can contribute to modeling efforts, which have 
been used in decision making during ongoing outbreaks to distribute resources. Despite the 
results herein, there is a continued need for surveillance of neglected tropical diseased and 
emerging viruses to bridge gaps in knowledge and proactively understand the dynamics of 




















APPENDIX. SYSTEMATIC REVIEW ARTICLES 
Articles meeting all inclusion criteria for literature search of OROV and C. paraensis. * indicates 
articles included from C. paraensis database search 
 
TITLE AUTHOR 
Oropouche Virus: a New Human Disease Agent from Trinidad, West 
Indies 
C.R. Anderson, et 
al.  
Occurance of arboviruses belonging to the C-, Bunyamwera and Guama 
groups, and of Oropouche, Junin, Tacaiuma and Kwatta viruse in man in 
the province of Brokopondo, Surinam: a serological survey 
HA van Tongeren 
et al.  
An outbreak of Oropouche virus disease in the vicinity of santarem, para, 
barzil 
FP Pinheiro et al.  
Oropouche Virus II. Epidemiological Observations During an Epidemic in 
Santarem, Para, Brazilian 1975 
K.E. Dixon et al.  
Epidemic Oropouche virus disease in northern Brazil JW LeDuc et al.  
Oropouche Virus Transmission in the Amazon River Basin of Peru DM Watts et al. 
Venezuelan Equine Encephalitis and Oropouche Virus Infections among 
Peruvian Army Troops in the Amazon Region of Peru 
DM Watts et al.  
Epidemiology of endemic Oropouche virus transmission in upper 
Amazonian Peru 
KJ Baisley et al. 
Serologic survey for yellow fever virus and other arboviruses among 
inhabitants of Rio Branco, Brazil, before and 3 months after receiving the 
YF 17D vaccine 
J Tavares-Neto et 
al. 
Exanthematous diseases and the 1st epidemic of dengue virus to occur in 
Manaus, Amazonas State, Brazil, during 1998-1999 
RM De Figueiredo 
et al.  
Reemergence of Oropouche fever, northern Brazil RS Azevedo et al. 
Assessing yellow fever risk in the Ecuadorian Amazon RO Izurieta et al.  
Oropouche fever epidemic in Northern Brazil: Epidemiology and 
molecular characterization of isolates 
HB Vasconcelos et 
al.  
Sporadic Oropouche infection, Acre, Brazil AC Bernardes et al. 
Etiology of acute undifferentiated febrile illness in the Amazon basin of 
Equador 
SR Manock et al.  
Oropouche fever outbreak, Manaus, Brazil, 2007-2008 MP Mouraao et al.  
Detection of St. Louis Encephalitis virus in dengue-suspected cases during 
a dengue 3 outbreak 
ACB Terzian et al.  
Arboviral etiologies of acute febrile illnesses in Western S. America, 2000-
2007 
BM Forshey et al.  
Iquitos virus: a novel reassortant Orthobunyavirus associated with human 
illness in Peru 
PV Aguilar et al. 
Short report: Identification of Oropouche orthbunyavirus in the 
cerebrospinal fluid of 3 patients in the Amazonas, Brazil 
M de Souza Bastos 
et al.  
Seroepidiological monitoring in sentinal animals and vectors as part of 
arbovirus surveillance in the State of Mato Grosso do Sul, Brazil 
PM Batista et al.  
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Detection of arboviruses of public health interest in free-living new world 
primates captured in Mato Grosso do Sul, Brazil 
PM Batista et al.  
Detection of herpesvirus, enterovirus, and arbovirus infection in patients 
with suspected central nervous system (CNS) viral infection in the Western 
Brazilian Amazon 
MS Bastos et al.  
Clinical and Virological Descriptive Study in the 2011 Outbreak of 
Dengue in the Amazonas, Brazil 
V  do Carmo Alves 
Martins et al.  
Detection of Oropouche virus segment S in patients and in Culex 
quinquefasciatus in the state of Mato Grosso, Brazil 
BF Cardoso et al.  
Detection of antibodies to Oropouche virus in non-human primates in 
Goiania City, Goias 
MM Gibrail et al.  
Serosurvey of selected abroviral pathogens in Free-ranging, 2-toed sloths 
and 3-toed sloths in Costa Rica, 2005-07 
S Medlin et al.  
Oropouche virus is detected in peripheral blood leukocytes from patients LK de Souza Luna 
et al.  
Silent emergence of Mayaro and Oropouche viruses in humans and Central 
Brazil 
VG da Costa et al.  
Neutralizing antibodies for orthobunyaviruses in Pantanal, Brazil A Pauvolid-Correa 
et al.  
Emerging and reemerging arboviruses: A new threat in Eastern Peru C Alva-Urcia et al.  
Human orthobunyavirus Infections, Tefe, Amazonas, Brazil FG Naveca et al.  
Isolation of Oropouche virus from febrile patient, Ecuador EL Wise et al.  
Oropouche virus associated aseptic meningoencephalitis, SE Brazil S Vernal et al.  
1st outbreak of Oropouche fever reported in a non-endemic western region 
of the Peruvian Amazon: molecular diagnosis and clinical characteristics 
W Silva-Caso et al.  
Real time RT-PCR for the detection and quantification of Oropouche virus A Rojas et al.  
Oropouche virus detection in febrile patients' saliva and urine samples in 
Salvador, Bahia, Brazil 
LM dos Santos 
Fonseca et al.  
Oropouche virus cases identified in Ecuador using an optimized qRT-PCR 
informed by metagenomic sequencing 
EL Wise et al.  
Oropouche infection a neglected arbovirus in patients with acute febrile 
illness from Peruvian coast 
J Martins-Luna et 
al.  
Oropouche virus detection in saliva and urine VA do Nascimento 
et al.  
1st register of an epidemic caused by Oropouche virus in the states of 
Maranhao and Goias, Brazil 
PF Vasconcelos et 
al.  
Outbreak of oropouche virus feveri n Serra Pelada, municpality of 
Curionopolis, Para, 1994 
AP Rosa et al.  
Sera of Peruvians with fever of unknown origin include viral nucleic acids 
from non-invertebrate hosts 
TG Phan et al.  
Detection of Oropouche viral circulation in Madre de Dios region, Peru 
(Dec 2015-Jan 2016) 
MP Garcia et al.  
Serological survey for arboviruses in Jururi, Para State, Brazil AC Cruz et al.  
Concurrent dengue and malaria in the Amazon region V dos Santos 
Santana et al.  
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Oropouche virus Isolation, Southeast Brazil Marcio Roberto 
Teixeira Nunes et 
al.  
Transmission of Oropouche virus from man to hampster by the midge 
Culicoides paraensis 
FP Pinheiro et al.  
Lack of evidence of sylvatic transmission of dengue viruses in the Amazon 
Rainforest near Iquitos, Peru 
MJ Turell et al.  
Diagnosis of Oropouche virus  infection by RT-Nested-PCR ML Moreli et al.  
Arboviruses in blood-donors: a study in the amazon region and in a small 
city with a dengue outbreak 
Lavezzo et al.  
The acre project: the epidemiology of malaria and arthropod-borne 
infections in a rural Amazonian population 
Silva-Nunes et al.  
Seroepidemiology of arboviruses in communities living under the 
influence of the lake of a hydroelectric dam in Brazil 
Brito et al.  
Surveillance of arboviruses in primates and sloths in the Atlantic forest, 
Bahia, Brazil 
Catenacci et al.  
Arbovirus investigation in patients from Mato Grosso during Zika and 
chickungunya virus introduction in Brazil, 2015-16 
Souza Costa et al.  
An epidemic of Oropouche virus in Belém. (Preliminary note). Pinheiro et al.  
Laboratory transmission of Oropouche virus by Culex Quinquefasciatus 
Say. 
AL Hoch et al.  
Oropouche Virus IV. Laboratory Transmission by Culicoides paraensis F.P. Pinheiro et al.  
Laboratory studies of a Brazilian strain of Aedes albopictus as a potential 
vector of Mayaro and Oropouche viruses 
GC Smith et al.  
Detection of abs against Icoaraci, Ilheus, and St. Louis Encephalitus 
arboviruses during yellow fever monitoring surveillance in Non-human 
primates in S. Brazil 
MAB Almeida  et 
al.  
Culicoides paraenesis infestations in the cities of the Itapocu river valley, 
S. Brazil* 
Felippe-Bauer et al.  
Culicoides species and potential hosts in ecotourism area of Lencois 
Maranhenses National park, Brazil* 
Costa et al.   
New report on the bionomics of Coquillettidia venezuelensis in temporary 
breeding sites * 
J Alencar et al.  
Culicidae selection of humans, chickens and rabbits in 2 different 
environments in the province of Chaco, Argentina* 
Stein et al.  
Preliminary investigation of Culicidae species in south pantanal, Brazil and 
their potential importance in arbovirus transmission* 
Pauvolid-Correa et 
al.  
Species Diversity, Seasonal, and Spatial Distribution of Mosquitoes 
(Diptera: Culicidae) Captured in Aotus Monkey-Baited Traps in a Forested 
Site Near Iquitos, Peru* 
Andrews et al.  
Seasonal distribution, biology, and human attraction patterns of culicine 
mosquioes in a forest near Puerto almendras, Iquitoes, Peru* 
Jones et al.  
Inventory of mosquitoes in conservation units in Brazilian tropical dry 
forests* 
CF Santos et al.  
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Mosquitoes (Diptera: Culicidae) From the Northwestern Brazilian 
Amazon: Padauari River* 
Hutchings et al. 
Composition and diversity of mosquitoes in urban parks in the south region 
of the city of Sao Paulo, Brazil* 
GC Carvalho et al.  
Ecological aspects of the potential arbovirus vectors in an urban landscape 
of S amazon, brazil* 
KJSP Vieira et al.  
Diversity patterns of hematophagous insects in Atlantic forest fragments 
and human-modifed areas of southern Bahia, Brazil* 
Catenacci et al.  
Mosquito fauna in parks in greater Sao Paulo, Brazil* MB Paula et al.  
Spatial and temporal distribution of Culicoides insignis and C. paraenesis 
in the subtropical mountain forest of Tucuman, northwest Argentina* 
Aybar et al.  
Changes in Relative Species Compositions of Biting Midges and an 
Outbreak of Oropouche virus in Iquitos, Peru* 
DR Mercer et al.  
Preliminary survey on the sanitary nuisance caused by culicoides in the 
department of Boyaca, Colombia* 
Santamaria et al.  
A study of culicoides in Rondonia, in the Brazilian Amazon: species 
comparison, relative abundance and potential vectors* 
Carvalho et al.  
Culicoides from Ceara state, northwest Brazil: Diversity, new records and 
bionomic approaches* 
Felippe-Bauer et al.  
New records and epidemiological potential of certain species of mosquito 
in the State of Rio Grande do Sul, Brazil* 
J da Cruz Cardoso 
et al.  
Diversity of biting midges of the genus Culicoides Latreille in the area of 
the Yacyreta Dam Lake between Argentina and Paraguay* 
MM Ronderos et al.  
Biting Rates and Developmental Substrates for Biting Midges in Iquitos, 
Peru* 
DR Mercer et al.  
Oropouche Virus III. Entomological observations from three epidemics in 
Para, Brazil, 1975* 
DR Roberts et al.  
Dermatozoonosis by Culicoides’ Bite in Salvador, State of Bahia, Brazil* Sherlock et al.  
Annotated list of the Ceratopogonidae (Diptera) of Suriname* Hudson et al. 
Diversity of Culicoides (diptera: Ceratopogonidae) in the National forest of 
Caxiuana, Melgaco, Para State, Brazil* 
MCA Santarem et 
al.  
New records of Culicoides Latreille (Diptera: Ceratopogonidae) from 
Peruvian Amazonian region* 
ML Felippe-Bauer 
et al.  
List of Culicoides biting midges (Diptera: Ceratopogonidae) from the state 
of Amazonas, Brazil, including new records* 
E de Sousa Farias 
et al.  
Simuliid Blackflies (Diptera: Simuliidae) and Ceratopogonid Midges 
(Diptera: Ceratopogonidae) as Vectors of Mansonella ozzardi (Nematoda: 
Onchocercidae) in Northern Argentina* 
Shelley et al.  
New records of biting midges of the genus Culicoides Latreille from 
Mexico (Diptera: Ceratopogonidae)* 
Huerta et al.  
Seasonal abundance of livestock-associated Culicoides species in 
northeastern Brazil* 
Carvalho et al.  
Infestation of Brazilian Peridomiciliary Areas by Culicoides (Diptera: 
Ceratopogonidae) in Humid and Semihumid Climates* 
Bandeira et al.  
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importance for vector-borne diseases in a rural area of central western 
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FAL Santos et al.  
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control of culicoides in northeastern Brazil* 
Bandeira et al.  
Isolation of viruses from mosquitoes collected In the Amazon basin region 
of Peru* 






































1. Kuno G, Chang GJ. Biological transmission of arboviruses: reexamination of and new 
insights into components, mechanisms, and unique traits as well as their evolutionary trends. 
Clin Microbiol Rev. 2005;18(4):608-37. 
 
2. Quah SR, Cockerham WC. International encyclopedia of public health. Second edition. 
ed. Amsterdam ; Boston: Elsevier/AP; 2017. 7 volumes p. 
 
3. Christofferson RC, Mores CN. Estimating the magnitude and direction of altered 
arbovirus transmission due to viral phenotype. PLoS One. 2011;6(1):e16298. 
 
4. Weaver SC. Prediction and prevention of urban arbovirus epidemics: A challenge for the 
global virology community. Antiviral Res. 2018;156:80-4. 
 
5. Conway MJ, Colpitts TM, Fikrig E. Role of the Vector in Arbovirus Transmission. Annu 
Rev Virol. 2014;1(1):71-88. 
 
6. Franz AW, Kantor AM, Passarelli AL, Clem RJ. Tissue Barriers to Arbovirus Infection 
in Mosquitoes. Viruses. 2015;7(7):3741-67. 
 
7. Mellor PS, Boorman J, Baylis M. Culicoides biting midges: their role as arbovirus 
vectors. Annu Rev Entomol. 2000;45:307-40. 
 
8. Daniel E. Sonenshine MR. Biology of Ticks Second Edition. 2014:180-210. 
 
9. Althouse BM, Vasilakis N, Sall AA, Diallo M, Weaver SC, Hanley KA. Potential for 
Zika Virus to Establish a Sylvatic Transmission Cycle in the Americas. Plos Neglect Trop D. 
2016;10(12). 
 
10. Valentine MJ, Murdock CC, Kelly PJ. Sylvatic cycles of arboviruses in non-human 
primates. Parasit Vectors. 2019;12(1):463. 
 
11. Garske T, Van Kerkhove MD, Yactayo S, Ronveaux O, Lewis RF, Staples JE, et al. 
Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from 
outbreak and serological data. PLoS Med. 2014;11(5):e1001638. 
 
12. Hassell JM, Begon M, Ward MJ, Fevre EM. Urbanization and Disease Emergence: 
Dynamics at the Wildlife-Livestock-Human Interface. Trends Ecol Evol. 2017;32(1):55-67 
. 
13. Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res. 
2010;85(2):328-45. 
 
14. Becker DJ, Washburne AD, Faust CL, Pulliam JRC, Mordecai EA, Lloyd-Smith JO, et 
al. Dynamic and integrative approaches to understanding pathogen spillover. Philos Trans R Soc 
Lond B Biol Sci. 2019;374(1782):20190014. 
 51 
 
15. Alexander C, Lewis, et. al The Ecology of Pathogen Spillover and Disease Emergence at 
the Human-Wildlife-Environment Interface. The Connections Between Ecology and Infectious 
Disease. 2018;5:267-89. 
 
16. LaDeau SL, Allan BF, Leisnham PT, Levy MZ. The ecological foundations of 
transmission potential and vector-borne disease in urban landscapes. Funct Ecol. 2015;29:889-
901. 
 
17. Curto de Casas SI, Carcavallo RU. Climate change and vector-borne diseases 
distribution. Soc Sci Med. 1995;40(11):1437-40. 
 
18. Lambin EF, Tran A, Vanwambeke SO, Linard C, Soti V. Pathogenic landscapes: 
interactions between land, people, disease vectors, and their animal hosts. Int J Health Geogr. 
2010;9:54. 
 
19. Ashford RW. When is a reservoir not a reservoir? Emerg Infect Dis. 2003;9(11):1495-6. 
 
20. Liang G, Gao X, Gould EA. Factors responsible for the emergence of arboviruses; 
strategies, challenges and limitations for their control. Emerg Microbes Infect. 2015;4(3):e18. 
 
21. Girard M, Nelson CB, Picot V, Gubler DJ. Arboviruses: A global public health threat. 
Vaccine. 2020;38(24):3989-94. 
 
22. Ushijima Y, Abe H, Nguema Ondo G, Bikangui R, Massinga Loembe M, Zadeh VR, et 
al. Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central 
Africa: increased risk of West Nile virus and dengue virus infections. BMC Infect Dis. 
2021;21(1):265. 
 
23. Mora-Salamanca AF, Porras-Ramirez A, De la Hoz Restrepo FP. Estimating the burden 
of arboviral diseases in Colombia between 2013 and 2016. Int J Infect Dis. 2020;97:81-9. 
 
24. Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L. Chikungunya 
virus infection: an overview. New Microbiol. 2013;36(3):211-27. 
 
25. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global 
distribution and burden of dengue. Nature. 2013;496(7446):504-7. 
 
26. Back AT, Lundkvist A. Dengue viruses - an overview. Infect Ecol Epidemiol. 2013;3. 
 
27. Dengue Vaccine [Internet]. 2019. Available from: 
https://www.cdc.gov/dengue/prevention/dengue-vaccine.html. 
 
28. Paixao ES, Teixeira MG, Rodrigues LC. Zika, chikungunya and dengue: the causes and 
threats of new and re-emerging arboviral diseases. BMJ Glob Health. 2018;3(Suppl 1):e000530. 
 
 52 
29. Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, et al. 
Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a 
case-control study. Lancet. 2016;387(10027):1531-9. 
 
30. Congential Zika Syndrome and Other Birth Defects [Internet]. 2021. Available from: 
https://www.cdc.gov/pregnancy/zika/testing-follow-up/zika-syndrome-birth-defects.html. 
 
31. Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D. An update on Zika virus infection. 
Lancet. 2017;390(10107):2099-109. 
 
32. Sharma A, Lal SK. Zika Virus: Transmission, Detection, Control, and Prevention. Front 
Microbiol. 2017;8:110. 
 
33. Zika Virus Treatment [Internet]. 2019. Available from: 
https://www.cdc.gov/zika/symptoms/treatment.html. 
 
34. Romero-Alvarez D, Escobar LE. Oropouche fever, an emergent disease from the 
Americas. Microbes Infect. 2018;20(3):135-46. 
 
35. Sakkas H, Bozidis P, Franks A, Papadopoulou C. Oropouche Fever: A Review. Viruses. 
2018;10(4). 
 
36. van Tongeren HA. Occurrence of arboviruses belonging to the C-, Bunyamwera and 
Guama groups, and of Oropouche, Junin, Tacaiuma and Kwatta viruses in man in the province of 
Brokopondo, Surinam: a serological survey. Trop Geogr Med. 1967;19(4):309-25. 
 
37. Oropouche virus disease-French Guiana, France [Internet]. 2020. Available from: 
https://www.who.int/csr/don/13-october-2020-oropouche-french-guiana-france/en/. 
 
38. Wise EL, Marquez S, Mellors J, Paz V, Atkinson B, Gutierrez B, et al. Oropouche virus 
cases identified in Ecuador using an optimised qRT-PCR informed by metagenomic sequencing. 
PLoS Negl Trop Dis. 2020;14(1):e0007897. 
 
39. Vernal S, Martini CCR, da Fonseca BAL. Oropouche Virus-Associated Aseptic 
Meningoencephalitis, Southeastern Brazil. Emerg Infect Dis. 2019;25(2):380-2. 
 
40. Sick F, Beer M, Kampen H, Wernike K. Culicoides Biting Midges-Underestimated 
Vectors for Arboviruses of Public Health and Veterinary Importance. Viruses. 2019;11(4). 
 
41. Lipkin WI, Firth C. Viral surveillance and discovery. Curr Opin Virol. 2013;3(2):199-
204. 
 




43. Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, Gianella A, et al. 
Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl 
Trop Dis. 2010;4(8):e787. 
 
44. Sudeep AB, Parashar D. Chikungunya: an overview. J Biosci. 2008;33(4):443-9. 
 
45. Zika virus Microcephaly and Guillain-Barre Syndrome [Internet]. 2016. Available from: 
https://apps.who.int/iris/bitstream/handle/10665/204718/zikasitrep_31Mar2016_eng.pdf. 
 
46. Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, 
et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a 
retrospective study. Lancet. 2016;387(10033):2125-32. 
 
47. Costa J, Ferreira EC, Santos C. COVID-19, Chikungunya, Dengue and Zika Diseases: An 
Analytical Platform Based on MALDI-TOF MS, IR Spectroscopy and RT-qPCR for Accurate 
Diagnosis and Accelerate Epidemics Control. Microorganisms. 2021;9(4). 
 
48. Yellow Fever [Internet]. 2019 [cited May 7, 2019]. Available from: 
https://www.who.int/news-room/fact-sheets/detail/yellow-fever. 
 
49. Organization WH. Oropouche virus disease-Peru. 2016. 
 
50. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus 
Disease (COVID-19) [Internet]. 2021 [cited February 16, 2021]. Available from: 
https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html. 
 
51. Flu Symptoms & Complications [Internet]. Available from: 
https://www.cdc.gov/flu/symptoms/symptoms.htm. 
 
52. Sutherland LJ, Cash AA, Huang YJ, Sang RC, Malhotra I, Moormann AM, et al. 
Serologic evidence of arboviral infections among humans in Kenya. Am J Trop Med Hyg. 
2011;85(1):158-61. 
 
53. Magalhaes T, Chalegre KDM, Braga C, Foy BD. The Endless Challenges of Arboviral 
Diseases in Brazil. Trop Med Infect Dis. 2020;5(2). 
 
54. Oidtman RJ, Espana G, Perkins TA. Co-circulation and misdiagnosis led to 
underestimation of the 2015-2017 Zika epidemic in the Americas. PLoS Negl Trop Dis. 
2021;15(3):e0009208. 
 
55. Moore M, Mitchell, et. al. Guidlines for Arbovirus Surveillance Programs in the Unites 
States 1993. 
 
56. Murray C. Infectious Disease Surveillance. International Encyclopedia of Public 
Health2017. p. 222-9. 
 
 54 
57. Barker CM. Models and Surveillance Systems to Detect and Predict West Nile Virus 
Outbreaks. J Med Entomol. 2019;56(6):1508-15. 
 
58. Davis JK, Vincent GP, Hildreth MB, Kightlinger L, Carlson C, Wimberly MC. 
Improving the prediction of arbovirus outbreaks: A comparison of climate-driven models for 
West Nile virus in an endemic region of the United States. Acta Trop. 2018;185:242-50. 
 
59. Scarpino SV, Meyers LA, Johansson MA. Design Strategies for Efficient Arbovirus 
Surveillance. Emerg Infect Dis. 2017;23(4):642-4. 
 
60. Luna LKD, Rodrigues AH, Santos RIM, Sesti-Costa R, Criado MF, Martins RB, et al. 
Oropouche virus is detected in peripheral blood leukocytes from patients. J Med Virol. 
2017;89(6):1108-11. 
 
61. West Nile Virus [Internet]. Available from: https://ldh.la.gov/index.cfm/page/539. 
 
62. Ciota AT, Keyel AC. The Role of Temperature in Transmission of Zoonotic Arboviruses. 
Viruses. 2019;11(11). 
 
63. Sang R, Lutomiah J, Said M, Makio A, Koka H, Koskei E, et al. Effects of Irrigation and 
Rainfall on the Population Dynamics of Rift Valley Fever and Other Arbovirus Mosquito 
Vectors in the Epidemic-Prone Tana River County, Kenya. J Med Entomol. 2017;54(2):460-70. 
 
64. Manore CA, Davis J, Christofferson RC, Wesson D, Hyman JM, Mores CN. Towards an 
early warning system for forecasting human west nile virus incidence. PLoS Curr. 2014;6. 
 
65. Esser HJ, Mogling R, Cleton NB, van der Jeugd H, Sprong H, Stroo A, et al. Risk factors 
associated with sustained circulation of six zoonotic arboviruses: a systematic review for 
selection of surveillance sites in non-endemic areas. Parasit Vectors. 2019;12(1):265. 
 
66. DeFelice NB, Birger R, DeFelice N, Gagner A, Campbell SR, Romano C, et al. Modeling 
and Surveillance of Reporting Delays of Mosquitoes and Humans Infected With West Nile Virus 
and Associations With Accuracy of West Nile Virus Forecasts. JAMA Netw Open. 
2019;2(4):e193175. 
 
67. WHO Coronavirus (COVID-19) Dashboard [Internet]. 2021. Available from: 
https://covid19.who.int. 
 
68. Putting the Cost of COVID-19 in Perspective [Internet]. Visual Capitalist. 2021. 
Available from: https://www.visualcapitalist.com/putting-the-cost-of-covid-19-in-perspective/. 
 
69. Fischer LS, Santibanez S, Hatchett RJ, Jernigan DB, Meyers LA, Thorpe PG, et al. CDC 




70. James LP, Salomon JA, Buckee CO, Menzies NA. The Use and Misuse of Mathematical 
Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic. Med 
Decis Making. 2021;41(4):379-85. 
 
71. About Dengue: What You Need to Know [Internet]. 2019. Available from: 
https://www.cdc.gov/dengue/about/index.html. 
 
72. Halasa YA, Shepard DS, Zeng W. Economic cost of dengue in Puerto Rico. Am J Trop 
Med Hyg. 2012;86(5):745-52. 
 
73. Colon-Gonzalez FJ, Peres CA, Steiner Sao Bernardo C, Hunter PR, Lake IR. After the 
epidemic: Zika virus projections for Latin America and the Caribbean. PLoS Negl Trop Dis. 
2017;11(11):e0006007. 
 
74. Elliott RM. Orthobunyaviruses: recent genetic and structural insights. Nat Rev Microbiol. 
2014;12(10):673-85. 
 
75. Hughes HR, Adkins S, Alkhovskiy S, Beer M, Blair C, Calisher CH, et al. ICTV Virus 
Taxonomy Profile: Peribunyaviridae. J Gen Virol. 2020;101(1):1-2. 
 
76. Pauvolid-Correa A, Campos Z, Soares R, Nogueira RMR, Komar N. Neutralizing 
antibodies for orthobunyaviruses in Pantanal, Brazil. PLoS Negl Trop Dis. 
2017;11(11):e0006014. 
 
77. Anderson CR, Spence L, Downs WG, Aitken TH. Oropouche virus: a new human disease 
agent from Trinidad, West Indies. Am J Trop Med Hyg. 1961;10:574-8. 
 
78. Mouraao MP, Bastos MS, Gimaqu JB, Mota BR, Souza GS, Grimmer GH, et al. 
Oropouche fever outbreak, Manaus, Brazil, 2007-2008. Emerg Infect Dis. 2009;15(12):2063-4. 
 
79. Silva-Caso W, Aguilar-Luis MA, Palomares-Reyes C, Mazulis F, Weilg C, Del Valle LJ, 
et al. First outbreak of Oropouche Fever reported in a non-endemic western region of the 
Peruvian Amazon: Molecular diagnosis and clinical characteristics. Int J Infect Dis. 
2019;83:139-44. 
 
80. Vasconcelos HB, Azevedo RS, Casseb SM, Nunes-Neto JP, Chiang JO, Cantuaria PC, et 
al. Oropouche fever epidemic in Northern Brazil: epidemiology and molecular characterization 
of isolates. J Clin Virol. 2009;44(2):129-33. 
 
81. Izurieta RO, Macaluso M, Watts DM, Tesh RB, Guerra B, Cruz LM, et al. Assessing 
yellow Fever risk in the ecuadorian Amazon. J Glob Infect Dis. 2009;1(1):7-13. 
 
82. Groot H. Estudios sobre virus transmitidos por arthropodos en Colombia. Revista de la 
Academia Colombiana de Ciencias. 1964;12(46). 
 
 56 
83. Rogers MB, Gulino KM, Tesh RB, Cui L, Fitch A, Unnasch TR, et al. Characterization 
of five unclassified orthobunyaviruses (Bunyaviridae) from Africa and the Americas. J Gen 
Virol. 2017;98(9):2258-66. 
 
84. Saeed MF, Wang H, Nunes M, Vasconcelos PF, Weaver SC, Shope RE, et al. Nucleotide 
sequences and phylogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol. 2000;81(Pt 
3):743-8. 
 
85. Dong H, Li P, Elliott RM, Dong C. Structure of Schmallenberg orthobunyavirus 
nucleoprotein suggests a novel mechanism of genome encapsidation. J Virol. 2013;87(10):5593-
601. 
 
86. Dutuze MF, Nzayirambaho M, Mores CN, Christofferson RC. A Review of 
Bunyamwera, Batai, and Ngari Viruses: Understudied Orthobunyaviruses With Potential One 
Health Implications. Front Vet Sci. 2018;5:69. 
 
87. Travassos da Rosa JF, de Souza WM, Pinheiro FP, Figueiredo ML, Cardoso JF, Acrani 
GO, et al. Oropouche Virus: Clinical, Epidemiological, and Molecular Aspects of a Neglected 
Orthobunyavirus. Am J Trop Med Hyg. 2017;96(5):1019-30. 
 
88. Weaver SC. Urbanization and geographic expansion of zoonotic arboviral diseases: 
mechanisms and potential strategies for prevention. Trends Microbiol. 2013;21(8):360-3. 
 
89. Pinheiro. An epidemic of Oropouche VIrus in Belem. Revista do Servico Especial de 
Saude Publica. 1962;12(1):15-23. 
 
90. Pinheiro FP, Travassos da Rosa AP, Gomes ML, LeDuc JW, Hoch AL. Transmission of 
Oropouche virus from man to hamster by the midge Culicoides paraensis. Science. 
1982;215(4537):1251-3. 
 
91. Pinheiro FP, Hoch AL, Gomes ML, Roberts DR. Oropouche virus. IV. Laboratory 
transmission by Culicoides paraensis. Am J Trop Med Hyg. 1981;30(1):172-6. 
 
92. Santamaria E, Cabrera OL, Zipa Y, Ferro C, Ahumada ML, Pardo RH. [Preliminary 
evaluation of the Culicoides biting nuisance (Diptera: Ceratopogonidae) in the province of 
Boyaca, Colombia]. Biomedica. 2008;28(4):497-509. 
 
93. Hoch AL, Pinheiro FP, Roberts DR, Gomes ML. Laboratory transmission of Oropouche 
virus by Culex Quinquefasciatus Say. Bull Pan Am Health Organ. 1987;21(1):55-61. 
 
94. F. Pinheiro ea. An epidemic of Oropouche virus in Belém. (Preliminary note). Revista do 
Servico Especial de Saude Publica. 1964;12(1):15-23. 
 
95. Manock SR, Jacobsen KH, de Bravo NB, Russell KL, Negrete M, Olson JG, et al. 
Etiology of acute undifferentiated febrile illness in the Amazon basin of Ecuador. Am J Trop 
Med Hyg. 2009;81(1):146-51. 
 57 
 
96. LeDuc JW, Hoch AL, Pinheiro FP, da Rosa AP. Epidemic Oropouche virus disease in 
northern Brazil. Bull Pan Am Health Organ. 1981;15(2):97-103. 
 
97. Pinheiro FP, Travassos da Rosa AP, Travassos da Rosa JF, Bensabath G. An outbreak of 
Oropouche virus diease in the vicinity of santarem, para, barzil. Tropenmed Parasitol. 
1976;27(2):213-23. 
 
98. Watts DM, Lavera V, Callahan J, Rossi C, Oberste MS, Roehrig JT, et al. Venezuelan 
equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon 
region of Peru. Am J Trop Med Hyg. 1997;56(6):661-7. 
 
99. Tilston-Lunel NL, Acrani GO, Randall RE, Elliott RM. Generation of Recombinant 
Oropouche Viruses Lacking the Nonstructural Protein NSm or NSs. J Virol. 2015;90(5):2616-27. 
 
100. Gutierrez B, Wise EL, Pullan ST, Logue CH, Bowden TA, Escalera-Zamudio M, et al. 
Evolutionary Dynamics of Oropouche Virus in South America. J Virol. 2020;94(5). 
 
101. Naveca FG, Nascimento VAD, Souza VC, Nunes BTD, Rodrigues DSG, Vasconcelos P. 
Multiplexed reverse transcription real-time polymerase chain reaction for simultaneous detection 
of Mayaro, Oropouche, and Oropouche-like viruses. Mem Inst Oswaldo Cruz. 2017;112(7):510-
3. 
 
102. Proenca-Modena JL, Sesti-Costa R, Pinto AK, Richner JM, Lazear HM, Lucas T, et al. 
Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I 
interferon signaling pathways in nonmyeloid cells. J Virol. 2015;89(9):4720-37. 
 
103. Figueiredo LT. Emergent arboviruses in Brazil. Rev Soc Bras Med Trop. 
2007;40(2):224-9. 
 
104. Martins-Luna J, Del Valle-Mendoza J, Silva-Caso W, Sandoval I, Del Valle LJ, 
Palomares-Reyes C, et al. Oropouche infection a neglected arbovirus in patients with acute 
febrile illness from the Peruvian coast. BMC Res Notes. 2020;13(1):67. 
 
105. Mattar S. Oropuche virus: A virus present but ignored. Revista MVZ Cordoba. 
2015;30(3). 
 
106. Dixon KE, Travassos da Rosa AP, Travassos da Rosa JF, Llewellyn CH. Oropouche 
virus. II. Epidemiological observations during an epidemic in Santarem, Para, Brazil in 1975. 
Am J Trop Med Hyg. 1981;30(1):161-4. 
 
107. Tavares-Neto J, Freitas-Carvalho J, Nunes MR, Rocha G, Rodrigues SG, Damasceno E, 
et al. [Serologic survey for yellow fever and other arboviruses among inhabitants of Rio Branco, 
Brazil, before and three months after receiving the yellow fever 17D vaccine]. Rev Soc Bras 
Med Trop. 2004;37(1):1-6. 
 
 58 
108. De Figueiredo RM, Thatcher BD, de Lima ML, Almeida TC, Alecrim WD, Guerra MV. 
[Exanthematous diseases and the first epidemic of dengue to occur in Manaus, Amazonas State, 
Brazil, during 1998-1999]. Rev Soc Bras Med Trop. 2004;37(6):476-9. 
 
109. Azevedo RS, Nunes MR, Chiang JO, Bensabath G, Vasconcelos HB, Pinto AY, et al. 
Reemergence of Oropouche fever, northern Brazil. Emerg Infect Dis. 2007;13(6):912-5. 
 
110. Bernardes-Terzian AC, de-Moraes-Bronzoni RV, Drumond BP, Da Silva-Nunes M, da-
Silva NS, Urbano-Ferreira M, et al. Sporadic oropouche virus infection, acre, Brazil. Emerg 
Infect Dis. 2009;15(2):348-50. 
 
111. Terzian AC, Mondini A, Bronzoni RV, Drumond BP, Ferro BP, Cabrera EM, et al. 
Detection of Saint Louis encephalitis virus in dengue-suspected cases during a dengue 3 
outbreak. Vector Borne Zoonotic Dis. 2011;11(3):291-300. 
 
112. Bastos Mde S, Figueiredo LT, Naveca FG, Monte RL, Lessa N, Pinto de Figueiredo RM, 
et al. Identification of Oropouche Orthobunyavirus in the cerebrospinal fluid of three patients in 
the Amazonas, Brazil. Am J Trop Med Hyg. 2012;86(4):732-5. 
 
113. Batista PM, Andreotti R, Chiang JO, Ferreira MS, Vasconcelos PF. Seroepidemiological 
monitoring in sentinel animals and vectors as part of arbovirus surveillance in the state of Mato 
Grosso do Sul, Brazil. Rev Soc Bras Med Trop. 2012;45(2):168-73. 
 
114. Batista PM, Andreotti R, Almeida PS, Marques AC, Rodrigues SG, Chiang JO, et al. 
Detection of arboviruses of public health interest in free-living New World primates (Sapajus 
spp.; Alouatta caraya) captured in Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop. 
2013;46(6):684-90. 
 
115. Bastos MS, Lessa N, Naveca FG, Monte RL, Braga WS, Figueiredo LT, et al. Detection 
of Herpesvirus, Enterovirus, and Arbovirus infection in patients with suspected central nervous 
system viral infection in the Western Brazilian Amazon. J Med Virol. 2014;86(9):1522-7. 
 
116. Martins Vdo C, Bastos Mde S, Ramasawmy R, de Figueiredo RP, Gimaque JB, Braga 
WS, et al. Clinical and virological descriptive study in the 2011 outbreak of dengue in the 
Amazonas, Brazil. PLoS One. 2014;9(6):e100535. 
 
117. Cardoso BF, Serra OP, Heinen LB, Zuchi N, Souza VC, Naveca FG, et al. Detection of 
Oropouche virus segment S in patients and inCulex quinquefasciatus in the state of Mato Grosso, 
Brazil. Mem Inst Oswaldo Cruz. 2015;110(6):745-54. 
 
118. Gibrail MM, Fiaccadori FS, Souza M, Almeida TN, Chiang JO, Martins LC, et al. 
Detection of antibodies to Oropouche virus in non-human primates in Goiania City, Goias. Rev 
Soc Bras Med Trop. 2016;49(3):357-60. 
 
 59 
119. de Souza Luna LK, Rodrigues AH, Santos RI, Sesti-Costa R, Criado MF, Martins RB, et 
al. Oropouche virus is detected in peripheral blood leukocytes from patients. J Med Virol. 
2017;89(6):1108-11. 
 
120. da Costa VG, de Rezende Feres VC, Saivish MV, de Lima Gimaque JB, Moreli ML. 
Silent emergence of Mayaro and Oropouche viruses in humans in Central Brazil. Int J Infect Dis. 
2017;62:84-5. 
 
121. Naveca FG, Nascimento VA, Souza VC, de Figueiredo RMP. Human Orthobunyavirus 
Infections, Tefe, Amazonas, Brazil. PLoS Curr. 2018;10. 
 
122. Fonseca L, Carvalho RH, Bandeira AC, Sardi SI, Campos GS. Oropouche Virus 
Detection in Febrile Patients' Saliva and Urine Samples in Salvador, Bahia, Brazil. Jpn J Infect 
Dis. 2020;73(2):164-5. 
 
123. Nascimento VAD, Santos JHA, Monteiro D, Pessoa KP, Cardoso AJL, Souza VC, et al. 
Oropouche virus detection in saliva and urine. Mem Inst Oswaldo Cruz. 2020;115:e190338. 
 
124. Vasconcelos PF, Travassos Da Rosa JF, Guerreiro SC, Degallier N, Travassos Da Rosa 
ES, Travassos Da Rosa AP. [1st register of an epidemic caused by Oropouche virus in the states 
of Maranhao and Goias, Brazil]. Rev Inst Med Trop Sao Paulo. 1989;31(4):271-8. 
 
125. Rosa AP, Rodrigues SG, Nunes MR, Magalhaes MT, Rosa JF, Vasconcelos PF. 
[Outbreak of oropouche virus fever in Serra Pelada, municipality of Curionopolis, Para, 1994]. 
Rev Soc Bras Med Trop. 1996;29(6):537-41. 
 
126. Cruz AC, Prazeres Ado S, Gama EC, Lima MF, Azevedo Rdo S, Casseb LM, et al. 
[Serological survey for arboviruses in Juruti, Para State, Brazil]. Cad Saude Publica. 
2009;25(11):2517-23. 
 
127. Santana Vdos S, Lavezzo LC, Mondini A, Terzian AC, Bronzoni RV, Rossit AR, et al. 
Concurrent Dengue and malaria in the Amazon region. Rev Soc Bras Med Trop. 
2010;43(5):508-11. 
 
128. Nunes MR, Martins LC, Rodrigues SG, Chiang JO, Azevedo Rdo S, da Rosa AP, et al. 
Oropouche virus isolation, southeast Brazil. Emerg Infect Dis. 2005;11(10):1610-3. 
 
129. Moreli ML, Aquino VH, Cruz AC, Figueiredo LT. Diagnosis of Oropouche virus 
infection by RT-nested-PCR. J Med Virol. 2002;66(1):139-42. 
 
130. Lavezzo LC, Dos Santos Santana V, Terzian AC, Mondini A, de Moraes Bronzoni RV, 
Speranca M, et al. Arboviruses in blood donors: a study in the Amazon region and in a small city 
with a dengue outbreak. Transfus Med. 2010;20(4):278-9. 
 
 60 
131. Silva-Nunes M, Malafronte Rdos S, Luz Bde A, Souza EA, Martins LC, Rodrigues SG, 
et al. The Acre Project: the epidemiology of malaria and arthropod-borne virus infections in a 
rural Amazonian population. Cad Saude Publica. 2006;22(6):1325-34. 
 
132. MTF Magalhães de Brito ea. Seroepidemiology of arbovirus in communities living under 
the influence of the lake of a hydroelectric dam in Brazil. Cadernos Saúde Coletiva. 
2018;26(1):1-6. 
 
133. Catenacci LS, Ferreira M, Martins LC, De Vleeschouwer KM, Cassano CR, Oliveira LC, 
et al. Surveillance of Arboviruses in Primates and Sloths in the Atlantic Forest, Bahia, Brazil. 
Ecohealth. 2018;15(4):777-91. 
 
134. de Souza Costa MC, Siqueira Maia LM, Costa de Souza V, Gonzaga AM, Correa de 
Azevedo V, Ramos Martins L, et al. Arbovirus investigation in patients from Mato Grosso 
during Zika and Chikungunya virus introdution in Brazil, 2015-2016. Acta Trop. 2019;190:395-
402. 
 
135. Almeida MAB, Santos ED, Cardoso JDC, Noll CA, Lima MM, Silva FAE, et al. 
Detection of antibodies against Icoaraci, Ilheus, and Saint Louis Encephalitis arboviruses during 
yellow fever monitoring surveillance in non-human primates (Alouatta caraya) in southern 
Brazil. J Med Primatol. 2019;48(4):211-7. 
 
136. Watts DM, Phillips I, Callahan JD, Griebenow W, Hyams KC, Hayes CG. Oropouche 
virus transmission in the Amazon River basin of Peru. Am J Trop Med Hyg. 1997;56(2):148-52. 
 
137. Baisley KJ, Watts DM, Munstermann LE, Wilson ML. Epidemiology of endemic 
Oropouche virus transmission in upper Amazonian Peru. Am J Trop Med Hyg. 1998;59(5):710-
6. 
138. Aguilar PV, Barrett AD, Saeed MF, Watts DM, Russell K, Guevara C, et al. Iquitos 
virus: a novel reassortant Orthobunyavirus associated with human illness in Peru. PLoS Negl 
Trop Dis. 2011;5(9):e1315. 
 
139. Alva-Urcia C, Aguilar-Luis MA, Palomares-Reyes C, Silva-Caso W, Suarez-Ognio L, 
Weilg P, et al. Emerging and reemerging arboviruses: A new threat in Eastern Peru. PLoS One. 
2017;12(11):e0187897. 
 
140. Phan TG, Del Valle Mendoza J, Sadeghi M, Altan E, Deng X, Delwart E. Sera of 
Peruvians with fever of unknown origins include viral nucleic acids from non-vertebrate hosts. 
Virus Genes. 2018;54(1):33-40. 
 
141. Garcia MP, Merino NS, Figueroa D, Marcelo A, Tineo VE, Manrique C, et al. [Detection 
of Oropouche viral circulation in Madre de Dios region, Peru (december 2015 to january 2016)]. 
Rev Peru Med Exp Salud Publica. 2016;33(2):380-1. 
 
 61 
142. Turell MJ, Gozalo AS, Guevara C, Schoeler GB, Carbajal F, Lopez-Sifuentes VM, et al. 
Lack of Evidence of Sylvatic Transmission of Dengue Viruses in the Amazon Rainforest Near 
Iquitos, Peru. Vector Borne Zoonotic Dis. 2019;19(9):685-9. 
 
143. Wise EL, Pullan ST, Marquez S, Paz V, Mosquera JD, Zapata S, et al. Isolation of 
Oropouche Virus from Febrile Patient, Ecuador. Emerg Infect Dis. 2018;24(5):935-7. 
 
144. Rojas A, Stittleburg V, Cardozo F, Bopp N, Cantero C, Lopez S, et al. Real-time RT-
PCR for the detection and quantitation of Oropouche virus. Diagn Microbiol Infect Dis. 
2020;96(1):114894. 
 
145. Tongeren HAEv. Occurance of arboviruses belonging to the C, Bunyamwera and Guama 
groups, and of Oropouche, Junin, Tacaiuma and Kwatta viruses in man in the province of 
Brokopondo, Surinam. Tropical and Geographical Medicine. 1967;19:309-25. 
 
146. Medlin S, Deardorff ER, Hanley CS, Vergneau-Grosset C, Siudak-Campfield A, Dallwig 
R, et al. Serosurvey of Selected Arboviral Pathogens in Free-Ranging, Two-Toed Sloths 
(Choloepus Hoffmanni) and Three-Toed Sloths (Bradypus Variegatus) in Costa Rica, 2005-07. J 
Wildl Dis. 2016;52(4):883-92. 
 
147. Felippe-Bauer ML, & Sternheim. Culicoides paraensis (Diptera: Ceratopogonidae) 
infesta- tions in cities of the Itapocú River Valley, southern Brazil. Entomological News. 
2008;119(2):185-92. 
 
148. Costa JC. Culicoides species (Diptera; Ceratopogonidae) and potential hosts in 
ecotourism area of Lencois Maranhensis National Park, Brazil. Pan-Amazonian Journal of 
Health. 2013;4(3):11-8. 
 
149. Alencar J, Pacheco JB, Correa FF, Silva Jdos S, Guimaraes AE. New report on the 
bionomics of Coquillettidia venezuelensis in temporary breeding sites (Diptera: Culicidae). Rev 
Soc Bras Med Trop. 2011;44(2):247-8. 
 
150. Pauvolid-Correa A, Tavares FN, Alencar J, Silva Jdos S, Murta M, Serra-Freire NM, et 
al. Preliminary investigation of Culicidae species in South Pantanal, Brazil and their potential 
importance in arbovirus transmission. Rev Inst Med Trop Sao Paulo. 2010;52(1):17-24. 
 
151. Santos CF, Silva AC, Rodrigues RA, de Jesus JS, Borges MA. Inventory of Mosquitoes 
(Diptera: Culicidae) in Conservation Units in Brazilian Tropical Dry Forests. Rev Inst Med Trop 
Sao Paulo. 2015;57(3):227-32. 
 
152. Hutchings RS, Hutchings RW, Menezes IS, Motta MA, Sallum MA. Mosquitoes 
(Diptera: Culicidae) From the Northwestern Brazilian Amazon: Padauari River. J Med Entomol. 
2016;53(6):1330-47. 
 
153. Carvalho GCd. Composition and diversity of mosquitoes (Diptera: Culicidae) in urban 
parks in the South region of the city of Sao Paulo, Brazil. Biota Neotropica. 2017;17(2). 
 62 
 
154. Vieira C, Thies SF, da Silva DJF, Kubiszeski JR, Barreto ES, Monteiro HAO, et al. 
Ecological aspects of potential arbovirus vectors (Diptera: Culicidae) in an urban landscape of 
Southern Amazon, Brazil. Acta Trop. 2020;202:105276. 
 
155. Catenacci LS, Nunes-Neto J, Deem SL, Palmer JL, Travassos-da Rosa ES, Tello JS. 
Diversity patterns of hematophagous insects in Atlantic forest fragments and human-modified 
areas of southern Bahia, Brazil. J Vector Ecol. 2018;43(2):293-304. 
 
156. Paula MB, et al. . Mosquito (Diptera: Culicidae) fauna in parks in greater São Paulo, 
Brazil. . Biota Neotropica [Internet]. 2015; 15(3). 
 
157. Carvalho LP, Pereira Junior AM, Farias ES, Almeida JF, Rodrigues MS, Resadore F, et 
al. A study of Culicoides in Rondonia, in the Brazilian Amazon: species composition, relative 
abundance and potential vectors. Med Vet Entomol. 2017;31(1):117-22. 
 
158. Felippe-Bauer ML, et al. Culicoides (Diptera: Ceratopogonidae) from Ceará State, 
northeastern Brazil: Diversity, new records and bionomic approaches. Cuadernos de 
Investigación UNED. 2018;11(2):137-44. 
 
159. Cardoso Jda C, Paula MB, Fernandes A, Santos ED, Almeida MA, Fonseca DF, et al. 
[New records and epidemiological potential of certain species of mosquito (Diptera, Culicidae) 
in the State of Rio Grande do Sul, Brazil]. Rev Soc Bras Med Trop. 2010;43(5):552-6. 
 
160. Roberts DR, Hoch AL, Dixon KE, Llewellyn CH. Oropouche virus. III. Entomological 
observations from three epidemics in Para, Brazil, 1975. Am J Trop Med Hyg. 1981;30(1):165-
71. 
 
161. Sherlock IA, Guitton N. Dermatozoonosis by Culicoides' bite (Diptera, Ceratopogonidae) 
in Salvador, State of Bahia, Brazil. I. Entomoligical survey. Mem Inst Oswaldo Cruz. 
1964;62(1):53-62. 
 
162. Santarém MCA, Confalonieri UEC, Felippe-Bauer ML. Diversity of Culicoides (Diptera: 
Ceratopogonidae) in the National Forest of Caxiuanã, Melgaço, Pará State, Brazil. Revista Pan-
Amazônica de Saúde. 2010;1:29-33. 
 
163. Farias EdS, Almeida JF, Pessoa FAC. List of Culicoides biting midges (Diptera: 
Ceratopogonidae) from the state of Amazonas, Brazil, including new records. Check List. 
2016;12(6). 
 
164. Carvalho LP, Silva FS. Seasonal abundance of livestock-associated Culicoides species in 
northeastern Brazil. Med Vet Entomol. 2014;28(2):228-31. 
 
165. Bandeira MCA, Da Penha A, Moraes JLP, Brito GA, Rebelo JMM. Infestation of 
Brazilian Peridomiciliary Areas by Culicoides (Diptera: Ceratopogonidae) in Humid and 
Semihumid Climates. J Med Entomol. 2016;53(5):1163-8. 
 63 
 
166. Leal-Santos FA. Species composition and fauna distribution of mosquitoes and its 
importance for vector-borne diseases in a rural area of central western Mato Grosso, Brazil. 
EntomoBrazilis. 2017;10(2). 
 
167. Bandeira M, Brito GA, da Penha A, Santos CLC, Rebelo JMM. The influence of 
environmental management and animal shelters in vector control of Culicoides (Diptera, 
Ceratopogonidae) in northeastern Brazil. J Vector Ecol. 2017;42(1):113-9. 
 
168. Andrews ES, Schoeler GB, Gozalo AS, Carbajal F, Lopez-Sifuentes V, Turell MJ. 
Species Diversity, Seasonal, and Spatial Distribution of Mosquitoes (Diptera: Culicidae) 
Captured in Aotus Monkey-Baited Traps in a Forested Site Near Iquitos, Peru. J Med Entomol. 
2014;51(6):1127-35. 
 
169. Jones JW, Turell MJ, Sardelis MR, Watts DM, Coleman RE, Fernandez R, et al. Seasonal 
distribution, biology, and human attraction patterns of culicine mosquitoes (Diptera: Culicidae) 
in a forest near Puerto Almendras, Iquitos, Peru. J Med Entomol. 2004;41(3):349-60. 
 
170. Mercer DR, Castillo-Pizango MJ. Changes in relative species compositions of biting 
midges (Diptera: Ceratopogonidae) and an outbreak of Oropouche virus in Iquitos, Peru. J Med 
Entomol. 2005;42(4):554-8. 
 
171. Mercer DR, Spinelli GR, Watts DM, Tesh RB. Biting rates and developmental substrates 
for biting midges (Diptera: Ceratopogonidae) in Iquitos, Peru. J Med Entomol. 2003;40(6):807-
12. 
 
172. Felippe-Bauer ML, Cáceres A, Silva CSd, Valderrama-Bazan W, Gonzales-Perez A, 
Costa JM. New records of Culicoides Latreille (Diptera: Ceratopogonidae) from Peruvian 
Amazonian region. Biota Neotropica. 2008;8:0-. 
 
173. Turell MJ, O'Guinn ML, Jones JW, Sardelis MR, Dohm DJ, Watts DM, et al. Isolation of 
viruses from mosquitoes (Diptera: Culicidae) collected in the Amazon Basin region of Peru. J 
Med Entomol. 2005;42(5):891-8. 
 
174. Stein M, Zalazar L, Willener JA, Almeida FL, Almiron WR. Culicidae (Diptera) 
selection of humans, chickens and rabbits in three different environments in the province of 
Chaco, Argentina. Mem Inst Oswaldo Cruz. 2013;108(5):563-71. 
 
175. Aybar V. Spatial and Temporal Distribution of Culicoides insignis and Culicoides 
paraensis in the Subtropical Mountain Forest of Tucuman, Northwestern Argentina. Florida 
Entomologist. 2011;94(4):1018-25. 
 
176. Ronderos MM, Greco NM, Spinelli GR. Diversity of biting midges of the genus 
Culicoides Latreille (Diptera: Ceratopogonidae) in the area of the Yacyreta Dam Lake between 
Argentina and Paraguay. Mem Inst Oswaldo Cruz. 2003;98(1):19-24. 
 
 64 
177. Shelley AJ, Coscaron S. Simuliid blackflies (Diptera: Simuliidae) and ceratopogonid 
midges (Diptera: Ceratopogonidae) as vectors of Mansonella ozzardi (Nematoda: 
Onchocercidae) in northern Argentina. Mem Inst Oswaldo Cruz. 2001;96(4):451-8. 
 
178. Huerta H. New records of biting midges of the genus Culicoides Latreille from Mexico 
(Diptera: Ceratopogonidae) Insecta Mundi. 2012:1-20. 
 
179. Hudson JE. Annotated list of the Ceratopogonidae (Diptera) of Suriname. Ent méd et 
Parasitol. 1986;24(4):293-301. 
 
180. Mayton EH, Tramonte AR, Wearing HJ, Christofferson RC. Age-structured vectorial 
capacity reveals timing, not magnitude of within-mosquito dynamics is critical for arbovirus 
fitness assessment. Parasit Vectors. 2020;13(1):310. 
 
181. Huang YS, Higgs S, Vanlandingham DL. Arbovirus-Mosquito Vector-Host Interactions 
and the Impact on Transmission and Disease Pathogenesis of Arboviruses. Front Microbiol. 
2019;10:22. 
 
182. Purse BV, Carpenter S, Venter GJ, Bellis G, Mullens BA. Bionomics of temperate and 
tropical Culicoides midges: knowledge gaps and consequences for transmission of Culicoides-
borne viruses. Annu Rev Entomol. 2015;60:373-92. 
 
183. Aide TM, Grau HR. Ecology. Globalization, migration, and Latin American ecosystems. 
Science. 2004;305(5692):1915-6. 
 
184. Laurance WF, Sayer J, Cassman KG. Agricultural expansion and its impacts on tropical 
nature. Trends Ecol Evol. 2014;29(2):107-16. 
 
185. Drewry J, Shandro J, Winkler MS. The extractive industry in Latin America and the 
Caribbean: health impact assessment as an opportunity for the health authority. Int J Public 
Health. 2017;62(2):253-62. 
 
186. Horowitz HW. Fever of unknown origin or fever of too many origins? N Engl J Med. 
2013;368(3):197-9. 
 
187. Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, et al. Rapid detection 
and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo 
hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-
time reverse transcription-PCR. J Clin Microbiol. 2002;40(7):2323-30. 
 
188. Kieffer A, Hoestlandt C, Gil-Rojas Y, Broban A, Castaneda-Cardona C, Rosselli D. The 
Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia. 
Value Health Reg Issues. 2019;20:60-5. 
 
 65 
189. Valencia-Marin BS, Gandica ID, Aguirre-Obando OA. The Mayaro virus and its 
potential epidemiological consequences in Colombia: an exploratory biomathematics analysis. 
Parasit Vectors. 2020;13(1):508. 
 
190. Aguilar PV, Estrada-Franco JG, Navarro-Lopez R, Ferro C, Haddow AD, Weaver SC. 
Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella. 
Future Virol. 2011;6(6):721-40. 
 
191. Feged-Rivadeneira A, Angel A, Gonzalez-Casabianca F, Rivera C. Malaria intensity in 
Colombia by regions and populations. PLoS One. 2018;13(9):e0203673. 
 
192. Perez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391(10115):82-94. 
 
193. Olivera MJ, Fory JA, Porras JF, Buitrago G. Prevalence of Chagas disease in Colombia: 
A systematic review and meta-analysis. PLoS One. 2019;14(1):e0210156. 
 
194. Quintero Velez JC, Aguirre-Acevedo DC, Rodas JD, Arboleda M, Troyo A, Vega 
Aguilar F, et al. Epidemiological characterization of incident cases of Rickettsia infection in 
rural areas of Uraba region, Colombia. PLoS Negl Trop Dis. 2018;12(10):e0006911. 
 
195. Kraemer MU, Sinka ME, Duda KA, Mylne AQ, Shearer FM, Barker CM, et al. The 
global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife. 
2015;4:e08347. 
 
196. Wu T, Perrings C, Kinzig A, Collins JP, Minteer BA, Daszak P. Economic growth, 
urbanization, globalization, and the risks of emerging infectious diseases in China: A review. 
Ambio. 2017;46(1):18-29. 
 
197. Voelkerding KV, Dames SA, Durtschi JD. Next-generation sequencing: from basic 
research to diagnostics. Clin Chem. 2009;55(4):641-58. 
 
198. Wolman DM, Kalfoglou AL, LeRoy L, Institute of Medicine (U.S.). Committee on 
Medicare Payment Methodology for Clinical Laboratory Services. Medicare laboratory payment 
policy : now and in the future. Washington, D.C.: National Academy Press; 2000. xvii, 241 p. p. 
 
199. Pena-Garcia VH, McCracken MK, Christofferson RC. Examining the potential for South 
American arboviruses to spread beyond the New World. Curr Clin Microbiol Rep. 
2017;4(4):208-17. 
 
200. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL. 
Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 
2005;11(8):1167-73. 
 
201. Hamer DH, Wilson ME, Jean J, Chen LH. Epidemiology, Prevention, and Potential 




202. Musso D, Rodriguez-Morales AJ, Levi JE, Cao-Lormeau VM, Gubler DJ. Unexpected 
outbreaks of arbovirus infections: lessons learned from the Pacific and tropical America. Lancet 
Infect Dis. 2018;18(11):e355-e61. 
 
203. McGregor BL, Connelly CR, Kenney JL. Infection, Dissemination, and Transmission 
Potential of North American Culex quinquefasciatus, Culex tarsalis, and Culicoides sonorensis 









































Christine Elizabeth Smith Walsh grew up in Greenwell Springs, Louisiana with her 
parents, older brother, younger brother, and surrounded by her large extended family. She 
participated in sports throughout childhood and entered into the workforce while still in high 
school. Christine graduated from Central High School with honors and pursued further education 
at LSU. She began working as a veterinary technician at the age of 18 to immerse herself into the 
world of veterinary medicine. She graduated from LSU with a Bachelor of Science degree in 
Animal Science in 2012. Christine continued to work as a veterinary technician before ultimately 
deciding to pursue her graduate degree in Pathobiological Sciences at LSU. Her Master’s degree 
was earned in Dr. Rebecca Christofferson’s laboratory, where she gained knowledge in a wide 
variety of disciplines including virology, epidemiology, statistics, and basic immunology. During 
her time as a graduate student, she was fortunate enough to participate in COVID-19 testing for 
local area hospitals with the River Road Testing Laboratory. During this experience, she was 
able to witness firsthand how diagnostics, research, and public health intersected to combat an 
ongoing pandemic. The work that she performed for her master’s degree focused on Oropouche 
virus, a neglected arbovirus, and the need for continued surveillance of other neglected tropical 
diseases. Prior to the completion of her master’s work, she became employed at the Louisiana 
Animal Disease Diagnostic Laboratory (LADDL). After graduation, Christine intends to 
continue to her career at LADDL using her background in small animal medicine and her 
education in infectious diseases.  
